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1  Introduction 
 
1.1 COPD 
 
Chronic obstructive pulmonary disease (COPD) is a slowly progressing 
syndrome of airflow limitation caused by chronic inflammation of the airways 
and lung parenchyma [1]. Chronic obstructive bronchitis, obstruction of small 
airways, and emphysema, with enlargement of air spaces and destruction of 
lung parenchyma, loss of lung elasticity, and closure of small airways 
constitutes the syndrome of patients with COPD (Figure. 1). It is to be noted 
that the extent of emphysema and obstructive bronchitis within individual 
patients can vary.  
 
 
Figure 1. COPD is characterized by bronchitis and emphysema [2] 
COPD is characterized by emphysema and chronic bronchitis. Emphysema comprises 
of the enlargement and destruction of the alveoli limiting the surface area for gas 
exchange. Chronic bronchitis is narrowing down of the small airways and deposition 
of mucus within them limiting the air flow inside. 
 
 
 
 
9 
 
1.1.1 Chronic bronchitis  
 
The inflammation of the bronchial epithelium with hypertrophy of the mucus 
glands and increased goblet cells characterizes chronic bronchitis. Chronic 
cough and sputum formation for at least three months is indicative of chronic 
bronchitis. In chronic bronchitis, there is a destruction of the airway cilia 
leading to the impaired efficiency of the mucociliary escalator. Mucus 
viscosity and mucus production are increased. There is also an increased 
susceptibility to infection. Repeated infections and inflammation cause 
irreversible damage of the airways structure due to narrowing and distortion of 
the peripheral airways. 
 
1.1.2 Emphysema 
 
The small air sacs, which constitute the lung, and where the exchange of 
oxygen and carbon dioxide takes place, are called alveoli. Any extrinsic or 
intrinsic damage to the alveoli, which results in air becoming trapped, may 
cause them to expand and rupture. Emphysema is characterized by the 
destruction of alveolar walls and loss of immanent lung elasticity. Emphysema 
leads to a progressive reduction of alveolar surface area, where exchange of 
oxygen and carbon dioxide between gas and blood takes place. 
Hyperinflation of the lung flattens the diaphragm. This leads to less effective 
contraction and impaired breathing mechanics. Over time, this results in severe 
airflow limitation and severe decrease of the forced expiratory volume.  
 
1.1.3 Diagnosis of COPD 
The clinical diagnose of COPD comprises patient history taking (for cigarette 
smoke or other toxin exposure as well as chronicity of the symptoms) and 
spirometery and is characterized by airway obstruction where the ratio of 
Forced Expiratory Volume (FEV1) and  Forced Vital Capacity (FEV1/ FVC) is 
less than 70% [3]. A short comparison of the spirometric definition of COPD is 
given in Table 1. 
10 
 
 
Table 1. The spirometric definition and grading of COPD [4] 
 
 
 
 
 
 
 
GOLD spirometric criteria for COPD severity 
I. Mild 
COPD 
* FEV1/FVC < 0.7 
* FEV1 > or = 80% 
predicted 
At this stage, the patient is 
probably unaware that 
lung function is starting to 
decline 
II. 
Moderate 
COPD 
* FEV1/FVC < 0.7 
* FEV1 50% to 79% 
predicted 
Symptoms during this 
stage progress, with 
shortness of breath 
developing upon exertion. 
III. Severe 
COPD 
* FEV1/FVC < 0.7 
* FEV1 30% to 49% 
predicted 
Shortness of breath 
becomes worse at this 
stage and COPD 
exacerbations are 
common. 
IV. Very 
Severe 
COPD 
* FEV1/FVC < 0.7 
* FEV1 < 30% 
predicted or FEV1 < 
50% predicted with 
chronic respiratory 
failure 
Quality of life at this stage 
is gravely impaired. COPD 
exacerbations can be life 
threatening. 
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1.1.4 Epidemiology  
Chronic obstructive pulmonary disease (COPD) represents a major health and 
economic burden with increasingly aging populations as shown in Figure 2.  
65 million people have moderate to severe chronic obstructive pulmonary 
disease according to the WHO. In 2005, more than 3 million people died of 
COPD which corresponds to approximately 5% of deaths globally. Most of the 
information available on COPD prevalence, morbidity and mortality comes 
from high-income countries. Even in those countries, accurate epidemiologic 
data on COPD are difficult and expensive to collect. It is known that almost 
90% of COPD deaths occur in low- and middle-income countries. 
COPD had been previously reported to be more prevalent in men than 
women. Due to the increased tobacco use among women in high income 
countries and the higher risk of exposure to indoor air pollution (such as 
biomass fuel used for cooking and heating) in low income countries; the 
disease now affects men and women almost equally. 
 
In 2002 COPD was the fifth leading cause of death. Total deaths from COPD 
are projected to increase by more than 30% in the next 10 years unless urgent 
action is taken to reduce the underlying risk factors, especially tobacco use. 
Estimates show that COPD becomes in 2020 the third leading cause of death 
worldwide [5].  
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Figure 2. COPD mortality worldwide in comparison to major diseases [6] 
 
1.1.5 Cigarette smoke 
 
Cigarette smoking is the primary cause of COPD. The tobacco smoke is a 
mixture of up to 4,700 chemicals with about 1010 particles/ml aerosolic 
components. The cigarette smoke components include about 60 known 
carcinogens and with each puff of cigarette the smoker takes in 1017 oxidant 
molecules [7]. Tobacco smoke is broadly divided into the mainstream and the 
side stream smoke. The mainstream is divided into a particulate solid phase 
(tar) and the gas phase (toxic gases, volatile organic compounds, free 
radicals, etc.). 
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The solid phase contains very high concentrations of free radicals (approx. 
1017 spins·g−1) with long lifetimes. The particulate phase is comprised of at 
least 3,500 chemical compounds and a high proportion of them are toxic, 
carcinogens or mutagens, (e.g. benzene, 2-napthylamine, 210Po, 226Ra, 228Ra, 
nickel, cadmium, benzo[a]pyrene, etc) [8].  The side stream smoke comprises 
of the solid and gas phases, containing higher concentrations of toxic and 
carcinogenic compounds and other volatile and semi volatile compounds [9]. 
The existence of the free radicals and oxidants in the gas phase remains in a 
steady state in which they are continuously formed or destroyed and their 
concentration increases as the smoke ages [10]. A few water components of 
the cigarette tar (ACT) can produce superoxide anions (O2
•−), which 
subsequently result in the formation of H2O2 and the reactive hydroxyl radical 
(HO•). These free radicals further cause oxidative stress. This leads to 
damage of the cellular membrane lipids, proteins, enzymes and most 
importantly the DNA. The side stream smoke consists of similar chemical 
components in the solid and gas phases and is also rich in highly reactive and 
short-lived free radicals. Passive smoking (or environmental tobacco smoke, 
ETS) has been proven to be a health hazard for non-smokers and is burden of 
major lung diseases [11]. 
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Figure 3. Major components of mainstream cigarette smoke [12] 
Detailed figure showing the composition of cigarette mainstream smoke (MS). The 
figure shows four vertical bars, the second vertical bar representing the main 
chemical constituents of MS smoke, labelled WHOLE SMOKE, dominated by N2 
(nitrogen) ~62% by weight, and O2 (oxygen) ~13% by weight. The 4.5% at the top of 
this symbolic cigarette is in the “TPM (Wet)” category, the main components of which 
are shown in the first vertical bar. The main constituent in the “VAPOR PHASE,” which 
constitutes 13.5% of the total, is shown in the third vertical bar. 
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1.1.6 Risk factors and current therapies 
The main precipitating factors are cigarette smoke, environmental pollution by 
inorganic and organic dust (e.g. due to open fireplaces), genetic 
predisposition, recurrent pulmonary infections, socioeconomic status and 
aging. Even if smoking or pollutant exposure is stopped, the condition often 
progresses at an accelerated rate compared with the normal age-related 
decline in FEV1. Hallmarks of COPD are chronic, self-perpetuating 
inflammation of the airways and gas exchange regions, loss of gas exchange 
tissue leading to emphysema, and collapse of small airways leading to 
increasing shortness of breath. Today, there is no causal treatment which 
could hold the progression of the disease. The currently available therapeutic 
armamentarium comprises bronchodilators such as muscarinic antagonists 
and beta adrenergic receptor agonists [13], anti-inflammatory drugs including 
inhaled and oral steroids and phosphodiesterase-4 inhibition [14, 15], and 
interventional or surgical procedures to relieve air trapping [16, 17]. These 
treatments improve symptoms like breathlessness and exercise intolerance 
and they may reduce the frequency of exacerbations of the disease, but their 
effects are often very limited.  
The fact of ongoing inflammation and tissue destruction despite of smoking 
cessation in COPD is an intriguing finding, which may be explained at least in 
part by the effects of premature cellular senescence and its associated 
secretory phenotype also known as Senescence Associated Secretory 
Phenotype or SASP.  
 
1.2 Cellular senescence  
 
Leonard Hayflick noticed in 1961 for the first time, that human tissue derived 
primary fibroblasts, which were maintained for multiple passages in culture, 
ceased to divide indefinitely. He discovered, that after a limited number of 
divisions, the cell proliferation gradually grinded to a complete halt [18]. The 
proliferation of the fibroblasts in culture showed three distinct phases: 1. Lag 
phase of slow proliferation during culture establishment, 2. Log phase where 
16 
 
the cells show rapid proliferation and 3. Stationary phase in which the cells 
gradually accomplish permanent arrest [18]. The possible causes of the 
transition to phase 3 were described by Hayflick [19] as “the finite lifetime of 
diploid cell strains in-vitro may be an expression of aging or senescence at the 
cellular level.” The term cellular senescence thus represented an irreversible, 
stable and long-term loss of proliferative capacity, despite continued viability 
and metabolic activity. The primary cells kept in culture cease to divide further 
after a replicative senescence. The replicative senescence, or Hayflick’s limit, 
occurs due to the fact, that each time when the cell divides, the telomeres at 
the chromosome ends become shorter. Telomeres are subject to attrition due 
to the fact that the DNA polymerase fails to completely replicate the lagging 
strands. In the early 1970s, Olovnikov [20] and Watson [21] independently 
described this so-called “end replication problem”, which contributes to 
telomere shortening. Thus, telomeres reflect the replicative history of a 
primary cell as a molecular clock [22].  
The telomere capping provides a protective and structural integrity at the end 
of the chromosomes. If the telomere shortening reaches a crucial minimal 
length, their protective structure is compromised. The cell recognizes this 
crucial loss in the chromosome as DNA damage and thus triggers a DNA 
damage response (DDR). DDR is associated with the appearance of DNA 
damage foci, that recruit important proteins of the DNA- repair machinery, 
such as γ-H2AX (a phosphorylated form of the histone variant H2AX) and the 
DDR proteins 53BP1(p53 Binding Protein 1), NBS1 (protein responsible for 
Nijmegen Breakage Syndrome 1) and MDC1 (Mediator of DNA damage 
Checkpoint protein 1). It has also been reported that the DNA damage kinases 
ATM (Ataxia Telangiectasia Mutated) and ATR are activated in senescent 
cells [23]. The amplification of the DDR signal activates the cell cycle 
checkpoint kinases CHK1 and CHK2. DDR-associated factors communicate 
with the cell cycle machinery via phosphorylation and activation of several cell 
cycle proteins, including CDC25 (a family of phosphatases) and the key 
regulator of cell cycle arrest p53. In addition, differential expression of p53 
isoforms has been linked to replicative senescence [24]. Together, these 
factors can either induce a transient proliferation arrest, allowing cells to repair 
their damage, or in case where the DNA damage seems to be irreparable, 
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cells are destined to undergo either senescence or apoptosis. The molecular 
decision making that determines the fate of these cells with irreparable DNA 
damage to senescence or apoptosis still remains elusive.  The cell type, the 
intensity and duration of the stress signal, as well as the nature of the 
damage, are likely to be important determinants [25].  
 
1.2.1 Markers of cellular senescence  
Senescent cells may be confused with quiescent or terminally differentiated 
cells as the distinction is not always straightforward. No marker or hallmark of 
senescence identified thus far is entirely specific to the senescent state. 
Further, not all senescent cells express all possible senescence markers. 
Nonetheless, senescent cells display several phenotypes, which, in 
aggregate, define the senescent state (Figure 4).  
 
Figure 4. Hallmarks of senescence  
Markers of senescence include senescence-associated beta-galactosidase activity at 
pH 6, formation of senescence associated heterochromatin foci, DNA damage foci, 
expression of cyclin dependent kinase inhibitors such as p16 INK4a or p21. If 
senescence induction includes DNA damage, the senescent cell releases several 
cytokines termed senescence associated secretory phenotype or SASP. 
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Salient features of senescent cells are: 
a) The senescence growth arrest is permanent and irreversible without 
genetic interventions [19]. 
 
(b) Senescent cells increase in size, sometimes enlarging more than twofold 
relative to the size of nonsenescent counterparts [19]. Senescent cells lose 
their original morphology. They look larger than their controlled counterparts 
and have a much larger flattened cytoplasm that contain many vacuoles and 
cytoplasmic filaments [26, 27], a bigger nucleus and nucleoli and are 
sometimes multinucleated [28, 29]. In some cases, senescent cells display an 
increase in the number of lysosomes and golgi [30]. 
 
(c) Senescent cells express a senescence-associated β-galactosidase [31] 
SA- β-galactosidase activity is expressed from GLB1, the gene encoding 
lysosomal beta-D-galactosidase. The levels of lysosomal-β-galactosidase 
protein increase during senescence [32]. The SA- β-galactosidase activity in 
senescent cells is believed to be present due to higher lysosomal mass in 
senescent cells [33]. 
 
(d) Most senescent cells express p16INK4a and p21 [34] . p16 INK4a and p21 
are key inhibitors of cyclin-dependent kinases (CDKs), the expression of 
which leads to cell cycle arrest. 
 
(e) Cells that senesce with persistent DDR signaling harbor persistent nuclear 
foci, termed DNA segments with chromatin alterations reinforcing senescence 
(DNA-SCARS) and are distinguishable from transient damage foci [35]. DNA-
SCARS foci contain activated DDR proteins. 
 
(f) Senescent cells with persistent DDR signaling secrete growth factors, 
proteases, cytokines and other factors that have potent autocrine and 
paracrine activities [36]. 
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(g) Senescence-associated heterochromatic foci (SAHF). Senescent cells 
exhibit increased heterochromatinization that reflects a compact chromatin 
structure, and are enriched for repressive histone modifications, the histone 
variant macro-H2A, HP1 proteins and HMGA proteins. SAHF can be 
visualized in cells as dense bright nuclear spots through DAPI staining.   
 
 
1.2.2 Premature cellular senescence 
Senescence can also be induced in the absence of any detectable telomere 
attrition or dysfunction by a variety of conditions, which will be discussed in the 
following section. The term premature explains the fact, that the senescence 
achieved in these cells is not caused by the replicative limit. Evidence for the 
existence of premature senescence in vivo has been accumulating rapidly and 
altogether points to the fact, that senescence plays an important and critical 
role in tumor suppression. Different ways of premature senescence is 
diagrammatically represented in Figure 5. 
Premature senescence is primarily due to environmental factors that exert 
cellular stress. Various factors like nutrients, growth factors, oxygen levels, 
absence of other cell types and extracellular matrix components, belonging to 
the original environment of the cells, can be detrimental for the acclimatization 
of the explanted culture in the new artificial environment. Changes in one or 
more of these factors can induce a culture shock, resulting in stress-induced 
senescence [37]. This type of cell cycle arrest is independent of telomere 
length.  
1.2.3  Stress-Induced Premature Senescence (SIPS) in-vitro 
Stress induced premature senescence or SIPS is primarily due to the cell 
culture medium that exerts cellular stress. Various factors like nutrients, 
growth factors, oxygen levels, absence of other cell types and extracellular 
matrix components belonging to the original environment of the cells can be 
detrimental for the acclimatization of the explanted culture in the new artificial 
environment. Changes in one or more of these factors can induce a culture 
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shock, resulting in stress-induced senescence [37]. This type of cell cycle 
arrest is independent of telomere length. Mouse embryonic fibroblasts (MEFs) 
undergo senescence after a limited number of passages in culture, despite 
their retaining of long telomeres. Murine cells, in contrast to most human cells, 
express telomerase [38] and have long telomeres [39]. Oxidative stress 
induces cessation of replication in cultured human cells [40-42] while the 
replicative potential of human melanocytes and epithelial cells depends largely 
on the composition of the culture medium used, as well as on the use of 
feeder layers [43-45]. Senescence of MEFs can be bypassed also by 
inactivation of p53 or simultaneous ablation of RB family genes [46-48]. Thus, 
the long term culture of mammalian cells requires not only telomere 
maintenance, but also optimal culture conditions [49]. 
1.2.4  Oncogene-Induced Premature Senescence (OIPS) in- 
vitro 
Transfection of the GTPase HRas, also known as  transforming protein p21 or 
HRAS, can induce cell cycle arrest in primary cells [50]. Cells arrested via 
HRas showed striking phenotypic resemblance to those cells which underwent 
replicative senescence. This phenomenon of oncogene mediated senescence 
has eventually come to be known as OIPS [51]. hTERT expression can 
rescue replicative senescence but not OIPS, confirming its independence from 
telomere attrition [52]. OIPS occurs in the early stages of tumor development 
both in mouse models and in humans [53-56]. These observations strongly 
indicate that OIPS checks the proliferation  of oncogenically stressed cells and 
maintains the tumor in premalignant state; by contrast, the absence of OIPS, 
which is caused by the mutation of the senescence-inducing pathways, leaves 
the road to oncogene-driven malignant progression unimpeded [53, 54]. 
Detection of senescence markers could be of prognostic value for those 
premalignant lesions, which are characterized by normal cell morphology and 
lack of invasive growth and are often associated with senescence. 
Senescence associated with the premalignant tumors is not paradoxical in 
context to the growth of tumor as only a fraction of the cells within a tumor are 
able to propagate successfully, while many undergo apoptosis or senescence 
triggered by the stress due to the aberrant intracellular and extracellular 
21 
 
conditions that are characteristically present in tumors [57]. Hence, it is the 
balance between cellular proliferation and apoptosis or senescence that 
determines the growth rate of a particular tumor [36].  
1.2.5  Tumor suppressor loss-Induced Premature Senescence 
(TIPS)  
Premature senescence can also be triggered by the loss of tumor suppressor 
molecules in mouse and human cells. PTEN (Phosphatase and tensin 
homolog) gene deficient MEFs undergo senescence, which is accompanied 
by induction of p53. Concomitant loss of p53 allows these cells to override the 
cytostatic effects of PTEN deletions [41]. Similarly, loss of NF1 causes 
senescence in-vitro, which is eventually accompanied by decreases in ERK 
and AKT activities [58]. Another example is VHL, loss of which triggers 
senescence in an RB- and p400-dependent manner [59].  
1.2.6 Senescence Associated Secretory Phenotype (SASP) 
The fact that the culture medium of senescent cells is enriched with secreted 
proteins has been shown in the past [60, 61]. When cells become senescent, 
they often display a senescence-associated secretory phenotype consisting of 
cytokines, growth factors and proteases, which collectively has been termed 
SASP by the Campisi group [62]. Daniel Peeper termed the same 
phenomenon SMS (Senescence Messaging Secretome) [63]. Contribution of 
senescence might seem to be passive, but the recent discovery of the SASP 
strongly suggests that senescence might have a more active and 
pathologically diverse role to play [63, 64]. The physiological role of SASP has 
been proposed to be a wound healing mechanism [65]. The initial observation 
of SASP implied, that senescence might not just be a tumor suppressor 
mechanism, but rather a double-edged sword within the tumor 
microenvironment [36]. SASP factors might contribute to signal immune cells 
for the removal of senescent cells. If this removal process is impaired, or if the 
number of senescent cells in a tissue is too high, the senescent cells might 
persist and maintain the secretory phenotype, exposing the local tissue 
persistently to the SASP. The secretion of these senescence-associated 
factors has the potential to detrimentally alter the local microenvironment, 
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leading to tissue dysfunction associated with ageing and disease.  However, It 
is also to be noted that SASP occurs in case senescence involves DNA 
damage. If senescence is mediated by factors not involving any DNA damage, 
there is no SASP response (Figure 5). 
 
Figure 5. Several factors could lead to senescence, but SASP response occurs only 
when senescence involves DNA damage. 
 
         
1.2.7  Molecular induction of SASP 
Cellular senescence is most often the result of nuclear DNA damage fuelling a 
chronic DNA damage response (DDR). The DDR pathway is triggered usually 
by ionizing radiation or other genotoxic events, resulting in DNA double-strand 
breaks. The DDR pathway initiates with the phosphorylation of histone H2AX 
by ATM (Ataxia Telangiectasia Mutated) that occurs at or near the DNA 
double-stranded break site and is required for phosphorylation of 53 Binding 
Protein-1(53-BP1) by ATM and localization of 53BP1 to nuclear repair foci 
[66]. 53BP1 function is important for coupling ATM to several of its 
downstream targets, including p53 and SMC1 (Structural Maintenance of 
Chromosomes protein 1). In the case of the checkpoint homolog 2 (Chk2) 
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kinase, the coupling mechanism to ATM seems to be largely independent of 
53BP1 and may involve another undefined member of the BRCT repeat family 
of proteins [66]. Upstream elements of the DDR signalling pathway like ATM, 
NBS1 (Nibrin) and CHK2 are necessary for full blown SASP, and additional 
crosstalk occurs between the DDR and cytokine secretion  in an autocrine 
loop, meaning that the secreted cytokines both control and are controlled by 
the DDR [67]. 
p53-knock out cells embark SASP response in the absence of senescence 
upon persistent DNA damage and in contrast, cells induced to senesce by 
p16INK4a over expression, but in the absence of DNA damage, do not initiate a 
SASP response [67]. This emphasizes the fact, that persistent DNA damage 
response is the major cause for SASP (Figure 6). It is also to be noted, that 
DDR signaling drives only a subset of SASP factors, but those include the 
potent inflammatory cytokines IL-6 and IL-8. Development of SASP is a slow 
process. SASP initiates only upon persistent DNA damage of sufficient 
magnitude. Delayed SASP might allow cells to attempt DNA repair before 
initializing the immune clearance signal through SASP. 
 
As a summary, senescence can be of replicative and premature type. 
Telomere attrition due to repeated replication leads to replicative senescence 
whilst the premature senescence occurs due to genotoxic stress, oncogene 
insertion or loss of a tumor suppressor. Stress induced senescence via the 
chronic or intense DNA damage leads to a DDR that engages ATM, NBS1 
and CHK2, leading to cellular senescence via the cell cycle effectors p53 and 
pRB [67]. Persistent DDR in turn is responsible for the SASP response.  
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Figure 6. Genotoxic stress, including cigarette smoke, may lead to persistent DNA 
double breaks which if unrepaired may lead to senescence and inflammation. 
DNA double strand breaks lead to a transient DNA damage response. However, if the 
DNA damage is persistent, this leads to activation of chemokine pathway. Persistent 
DNA damage may further drive the cell to senescence. Senescent cells activate a self-
amplifying secretory network (SASP) in which CXCR2-activation reinforces growth 
arrest. 
 
1.2.8  Paradoxical role of senescence: 
Although senescence represents a halt in cell division and thought to possess 
tumor suppressive capabilities, it has been shown that senescent cells could 
promote tumor formation and may have a role in tissue repair as well. Cell 
cycle arrest is the major mechanism by which cellular senescence suppresses 
malignant tumorigenesis [64, 68, 69]. However, some of the factors secreted 
by senescent cells help to reinforce the senescence growth arrest in an 
autocrine manner as well, for example the pro-inflammatory cytokines IL 
(interleukin)-6 and IL-8, but also factors such as the pro-apoptotic protein 
IGFBP (insulin-like growth factor binding protein)-7 and PAI (plasminogen 
activator inhibitor)-1. Many evidences confirm the tumor suppressor nature of 
senescence response in both mice and humans [70]. It seems paradoxical 
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that senescent cells secrete factors that may also promote cancer progression 
[36, 62]. Examples of such SASP factors include amphiregulin and GRO 
(growth-related oncogene)-α, which stimulate cell proliferation; VEGF 
(vascular endothelial growth factor), which stimulates angiogenesis; and the 
pro-inflammatory cytokines IL-6 and IL-8, which can induce an epithelial-to-
mesenchyme transition and epithelial cell migration and invasion [71]. There 
are a few evidences where senescence has been linked to tissue repair or 
regeneration [72, 73]. 
These evidences suggest that senescent cells feature a paradoxical 
phenomenon and the effect might be context dependent. Senescence has 
thus been viewed as a form of antagonistic pleiotropy, in which it is beneficial 
early in life, but detrimental at a later old stages of life [64]. 
 
Figure 7. Senescence as an example of antagonistic pleiotropy 
Benefits of senescence include tumor suppression and wound healing early in life and 
the harms include aging and cancer which could be detrimental later in life. 
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1.2.9 COPD, aging and cellular senescence  
Aging has an influence on development of COPD and at the same time COPD 
has been reported to be a disease of premature lung tissue aging [74, 75]. 
The progressive decline of tissue homeostasis after a certain span 
(reproductive age) of life is termed as aging. Aging leads to an increasing 
susceptibility of disease and causes the failure of organs due to oxidative 
stress induced premature senescence and the replicative exhaust due to 
telomere shortening (replicative senescence). Environmental stress, such as 
cigarette smoke or other pollutants accelerate the aging of lung cells through 
oxidative stress, thereby inducing accelerated progression of COPD in some 
patients. The striking fact that only 25% of the cigarette smokers develop 
COPD points towards additional “hits” by infections as well as to genetic 
variability and predisposition for the disease. It has also been suggested that 
human beings possessing different length of telomeric DNA might elicit 
variable susceptibility for the disease [76].  
It has been reported that cigarette smoking causes premature cellular 
senescence in lungs. In-vitro exposure of human lung epithelial cells to 
cigarette smoke extract results in an increased expression of SA-β-gal 
(senescence-associated β-galactosidase), a marker of cellular senescence 
[77]. Cultured lung fibroblasts from patients with emphysema show increased 
expression of SA-β-gal and decreased proliferative capacity in-vitro, when 
compared with those from healthy smokers [78, 79]. 
In several health disorders related to age, cigarette smoking is considered to 
be an important risk factor. Cigarette smoking is associated with increased 
systemic inflammation and oxidative stress [80]. This also supports the fact 
that extra pulmonary manifestations of COPD might include muscle wasting, 
cardiovascular disease or osteoporosis [81]. It is not mere coincidence but an 
established fact that these manifestations are also common characteristics of 
aging [82]. Elderly individuals (more than 60 years) possess a higher COPD 
disease rate than younger groups, independent of their history of exposure to 
tobacco smoke. The aging lung normally shows progressive distal air space 
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enlargement, with loss of gas-exchanging surface area and the support of the 
alveolar attachments for peripheral airways [83].  Lung function declines in 
elderly healthy individuals normally but is accelerated in patients with COPD 
[84]. One of the prominent possible causes for the lung function decline might 
be the elastin fiber fragmentation which also is associated with age [84, 85]. 
Although the structural changes in the lung are thought to be non-destructive, 
in contrast with smoking-induced emphysema [85] , they do have functional 
consequences, resulting in a loss of elastic recoil of the lungs, an increase in 
residual volume and functional residual capacity or over-inflation of the lungs.  
This loss of elastin fibers is similar to that which occurs with aging in the skin, 
resulting in loss of elasticity and skin wrinkling which is enhanced by smoking 
[86]. Interestingly, the degree of skin wrinkling correlates with quantitative 
measurements of emphysema by CT (computed tomography) scanning [87]. 
Thus cigarette smoking seems to cause elastolysis both in the lungs and 
systemically in the skin [88], suggesting that cigarette smoke may accelerate 
the aging process [89]. 
 
1.2.10   Similarities between the secretory profile of 
senescescent cells and inflammation in COPD 
 
Patients with COPD show severe increase in inflammatory molecules along 
with various others which was collectively termed COPD associated secretory 
phenotype or CASP. The link between senescence and COPD arises from the 
fact that each of them primarily is the result of oxidative abuse. Oxidative 
stress via Cigarette smoke/noxious gas causes persistent DNA damage in 
alveolar cells further leading to premature pulmonary senescence. 
Senescence, mediated via persistent DNA damage, leads to a secretory 
phenotype as discussed above (Figure 6). It is interesting to note that both 
senescence and COPD display a prominent secretory phenotype associated 
with it. The factors that have been reported to be upregulated in COPD show 
clear resemblance to that of SASP, suggesting a significant link between the 
two.  
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Below, a review of the striking similarities between the secretory phenotypes 
of senescence (SASP) and COPD is displayed. A summarized version is 
tabularized for ease in Table 2. 
1.2.11  Interleukins and chemokines 
 
IL-1, IL-6, IL-8 (CXCL-8), GROα, GROβ, GROγ, have been previously shown 
to be upregulated in senescescent cells [62]. These are upregulated in COPD 
as well [90, 91]. Monocyte Chemoattractant Protein 2 or MCP 2, Macrophage 
Inflammatory Protein (MIP)-1α and 3α levels are increased in senescent cells 
[62, 92]. Similarly in COPD, MCP-1, and IL-8 were increased in sputum, with 
further increases during exacerbations, and the bronchiolar epithelium 
overexpressed MCP-1, its receptor CCR2, MIP1α, and IL-8. MCP-1 and 
CCR2 were involved in the recruitment of macrophages and mast cells into 
the airway epithelium in COPD [93, 94]. Inflammatory cytokines such as the 
colony-stimulating factors (CSFs, including GM-CSF and G-CSF) are secreted 
at high levels by senescent fibroblasts [62]. Strikingly the concentrations of 
GM-CSF in BAL fluid are also increased in stable COPD and significantly 
elevated during exacerbations [95]. Macrophage migration inhibitory factor 
(MIF) is upregulated in senescence and has recently been forwarded as a 
critical regulator of inflammatory conditions and it has been hypothesized that 
MIF may have a role in the pathogenesis of asthma and chronic obstructive 
pulmonary disease (COPD). 
1.2.12  Growth factors 
 
Growth factors like epithelial growth factor (EGF), basic fibroblast growth 
factor (bFGF), vascular endothelial growth factor (VEGF) and angiogenin have 
been shown to be upregulated significantly in senescent cell culture media. 
EGF, bFGF, VEGF and angiogenin have also been reported to be upregulated 
in COPD [96, 97]. The insulin-like growth factor (IGF) and its IGF receptor 
have a major role in SASP response. Senescent endothelial, epithelial, and 
fibroblast cells express high levels of almost all the IGF-binding proteins 
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(IGFBPs), including IGFBP-2, 3, 4, 5, and 6 [62, 92, 98, 99]. Recently, 
activation of the BRAF oncogene in primary fibroblasts was shown to lead to 
the secretion of IGFBP-7, which acts through autocrine/paracrine pathways to 
induce senescence and apoptosis in neighboring cells [100]. Strikingly, lung 
fibroblasts from emphysema patients also showed upregulation of insulin-like 
growth factor-binding protein-3 (IGFBP-3) and IGFBP-related protein-1 
(IGFBP-rP-1) [78].  
1.2.13  Proteases and their regulators 
Senescent cells secrete a myriad of proteases in addition to soluble signaling 
cytokines and growth factors. The main proteases are the matrix 
metalloproteinases (MMPs). MMPs are a large family of zinc-dependent 
proteinases that regulate the destruction of extracellular matrix components 
[101]. The MMP family members that are consistently upregulated in human 
and mouse fibroblasts undergoing replicative or stress-induced senescence 
are stromelysin-1 and -2 (MMP-3 and -10, respectively) and collagenase-1 
(MMP-1) [102-106]. Similarly in COPD there is an increase in bronchoalveolar 
lavage concentrations and macrophage expression of MMP-1 (collagenase) 
and MMP-9 (gelatinase B) in patients with emphysema [107-109]. Alveolar 
macrophages from normal smokers express more MMP-9 than those from 
normal subjects [110], and there is an even further increase in cells from 
patients with COPD [111], which has greatly enhanced elastolytic activity 
[112]. MMP-9 and the ratio of MMP-9 to TIMP-1 are increased in induced 
sputum of patients with COPD [113, 114]. MMP-8 and MMP-9 do not only act 
as secreted enzymes, but they are also bound to cells where they exert 
elastolytic activity.  
Another family of proteases present in the SASP comprises serine proteases 
and regulators of the plasminogen activation pathway. Members of this family 
include urokinase or tissue-type plasminogen activators (uPA or tPA, 
respectively), the uPA receptor (uPAR), and inhibitors of these serine 
proteases (PAI 1 and 2) [92, 115]. Indeed, a >50-fold increase in plasminogen 
activator activity has been reported in senescent endothelial cells and lung 
and skin fibroblasts [92, 116, 117]. PAI-1 is also upregulated in fibroblasts and 
endothelial cells from aged donors [92, 118-120]. Induced sputum of COPD 
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patients also has been shown to contain significantly increased u-PAR, PAI-1, 
and IL-8 compared to the control subjects [121].  
1.2.14  Shed receptors or ligands 
Shed receptors include ICAM-1 (Intercellular Adhesion Molecule 1), -3, 
osteoprotegerin, TRAIL-R3, sTNFR1, Fas, STNFR2, uPAR and EGF-R, which 
are present at high levels in the extracellular milieu of senescent fibroblasts 
and are also found to be upregulated in COPD [122-124]. In fact, 
osteoprotegerin in sputum might be a potential biomarker in COPD [125].  
1.2.15  Non protein factors, extra cellular matrix and reactive 
oxygen species  
Non protein factors upregulated upon senescence include prostaglandin E2 
(PGE2) [126] and Cox-2, the enzyme responsible for the production of PGE2 
and other prostaglandins. These act in an autocrine or paracrine way. 
Similarly, it has been reported that the concentration of prostaglandin PGE2 in 
exhaled breath of COPD patients increases significantly [127]. This is likely to 
be derived from cyclooxygenase-2 (COX-2), which is expressed in alveolar 
macrophages [128]. There is also an increased COX-2 expression in alveolar 
macrophages from patients with COPD compared with normal control subjects 
[129].  
Fibronectin is a large multidomain glycoprotein found in connective tissue, on 
cell surfaces, and in plasma and other body fluids. It interacts with a variety of 
macromolecules, including cell-surface receptors, components of the 
cytoskeleton, and other ECM molecules. Through its interactions with cell-
surface receptors, primarily integrins, fibronectin can affect cell adhesion, 
survival, growth, and migration. Fibronectin production is upregulated in 
prematurely aging Werner syndrome fibroblasts [130]. Moreover, cells 
undergoing premature cellular senescence in culture and in-vivo show 
increased fibronectin expression [131]. Data from previous studies suggest a 
similar profile of ECM molecules including fibronectin in COPD [132]. 
Senescent cells have been shown to release nitric oxide and reactive oxygen 
species due to alterations in inducible nitric oxide synthase (iNOS), endothelial 
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nitric oxide synthase (eNOS), and superoxide-dismutase activities [92, 133-
137]. These reactive molecules are known modulators of cellular phenotype, 
such as the differentiation of monocytes. In addition, these molecules can 
enhance cancer cell aggressiveness and can promote aging and age-related 
degeneration [138, 139]. Similarly inflammatory and structural cells that are 
activated in the airways of patients with COPD also produce ROS, including 
neutrophils, eosinophils, macrophages, and epithelial cells [140]. Superoxide 
anions (O2·
-) are generated by NADPH oxidase, and this is converted to 
hydrogen peroxide (H2O2) by superoxide dismutases. H2O2 is then dismuted 
to water by catalase. O2·
- and H2O2 may interact in the presence of free iron to 
form the highly reactive hydroxyl radical (·OH). O2·
- may also combine with 
NO to form peroxynitrite, which also generates ·OH [141]. Nitrosylation and 
oxidation of lung proteins is a prominent finding in COPD and emphysema. 
The genetic ablation as well as pharmacological inhibition of inducible NOS 
prevented and reversed cigarette smoke induced emphysema in mice [142].  
Table 2. Similarities between the secretory profile of senescent cells and cytokine 
profiles of the lungs in COPD  
SASP factors Secretory profile for Senescent 
Cells [62, 92] 
Secretory Profile of COPD lung 
Interleukins  
 
 
[90, 91, 143] 
IL-6 
 
↑ 
 
↑ 
 
IL-1a, -1b 
 
↑ 
 
↑ 
 
IL-13 
 
↑ 
 
↑ 
 
Chemokines (CXCL, CCL) 
 
 
 
[93, 94] 
 
IL-8 
 
↑ 
 
↑ 
 
GRO-α,-β,-γ 
(Growth-Related Oncogene) 
↑ 
 
↑ 
 
MCP-2 
(monocyte chemoattractant protein) 
↑ 
 
↑ 
 
MIP-1a, 3a 
(macrophage inflammatory protein) 
↑ 
 
↑ 
 
Other inflammatory factors 
 
 
 
 
[95, 144] 
GM-CSF 
(granulocyte macrophage colony 
stimulating factor) 
↑ 
 
↑ 
 
MIF 
(macrophage migration inhibitory 
factor) 
↑ 
 
↑ 
 
Growth factors and regulators   
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EGF 
(endothelial growth factor) 
↑ 
 
↑[145] 
 
bFGF 
(basic fibroblast growth factor) 
↑ 
 
↑[132, 146] 
 
VEGF 
(vascular endothelial growth factor) 
↑ 
 
↑[96] 
 
Angiogenin 
 
↑ 
 
↑[96] 
 
IGFBP-3, 1, 2, 5 ( Insulin like growth 
factor binding protein) 
↑ 
 
↑[78] 
 
Proteases and regulators 
 
  
MMP-1, -3, -10, -12, -13, -14 
(matrix metalloproteinase) 
↑[102-106] 
 
↑[107-110] 
 
 
PAI-1, -2, uPAR 
(plasminogen activator inhibitor) 
(urokinase-type plasminogen 
activator) 
 
↑[98, 117-119, 147] 
 
↑[148, 149] 
 
Cathepsin B 
 
↑ 
 
↑[150] 
 
Soluble or shed receptors or ligands 
 
 
 
 
ICAM-1, -3 
(intercellular adhesion molecule) 
↑ 
 
↑[122, 151] 
 
OPG 
(osteoprotegerin) 
↑ 
 
↑[152] 
 
TRAIL-R3, sTNFRI, Fas 
sTNFRII 
(tumor necrosis factor–related 
apoptosis-inducing ligand) 
(soluble tumor necrosis factor 
receptor) 
↑ 
 
↑[153] 
 
uPAR 
(urokinase-type plasminogen 
activator receptor) 
↑[115] 
 
↑[115, 149] 
 
EGF-R 
(endothelial growth factor receptor) 
↑ 
 
↑[97] 
 
Nonprotein factors 
 
  
PGE2 
(prostaglandin E2) 
↑ 
 
↑[127, 129] 
 
Nitric oxide 
 
↑ 
 
↑[135, 141, 142] 
 
Reactive oxygen species 
 
↑ 
 
↑[154] 
 
Extracellular Matrix proteins 
 
 [132, 155] 
Fibronectin 
 
↑ 
 
↑ 
 
Collagens 
 
↑ 
 
↑ 
 
Laminin 
 
↑ 
 
↑ 
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1.3 DNA damage and DNA repair response 
 
 
Oxidative stress leads to damage of various molecules within the cell, DNA 
being most crucial. DNA damage has been shown to be accumulated in 
various tissues such as brain, liver, muscle, kidney, liver etc.  Evolution 
facilitated the eukaryotic cells to possess advanced multiple mechanisms to 
counter the DNA damage and control stress or age-associated damage to 
their genomes. 
Damaged DNA has been shown to accumulate during aging in many tissues, 
including brain, muscle, kidney and liver. Cellular Senescence involves DNA 
damage as well. However, it remains elusive if DNA damage is entirely a 
product of the aging process or the cause. Furthermore, several studies 
suggest that dietary (calorie) restriction reduces the amount of age-
associated oxidative DNA damage. Although, senescence could exist 
independent of any DNA damage, many of the aforementioned triggers of 
senescence usually elicit the DDR. DNA damage engages the p53 and pRB 
pathways. Thus, it is not surprising that the DNA damage response (DDR) is 
an important effector pathway through which senescence is established. In 
fact, telomere attrition, oncogene activation, or ionizing radiation all induce 
senescence through activation of the DDR [23]. A simplified DDR response 
is represented in Figure 8. 
 
End replication problem of the DNA leads to the progressive telomere 
shortening and is a well-documented trigger of the DNA damage response. 
It has been reported that replicative senescent cells could accumulate 
several markers of DNA damage including phosphorylated γ-H2AX, SMC1, 
RAD17, CHK1 and CHK2 [23]. The study further revealed that γ-H2AX was 
enriched at subset of sub telomeric regions of chromosomes   that   have   
been   shown   to   have   particularly   short   telomeres. In contrast, 
inactivation of the DNA response through expression of dominant negative 
forms of ATM, ATR, CHK1 and CHK2 enabled replicative senescent cells to 
resume DNA replication. Further, it has been shown that  DNA  damage  
occurring  at  telomeres  cannot  be effectively repaired, which results in 
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the presence of chronic DNA damage foci, a persistent DDR and 
establishment of senescence [156]. 
 
Oncogene mediated senescence have also been reported to involve DDR.  
Furthermore, it has been demonstrated that oncogenic activation indeed 
initiates a DDR by  causing  hyper-replication  that  results  in  DNA  
double-strand  breaks  and improperly terminated replication forks [157, 
158]. Inactivation of CHK2 not only abolishes H-RAS-induced senescence 
but also results in cell transformation, highlighting the importance of an intact 
DDR for establishment of OIS [158].  
 
Finally, it is to be emphasized that the DDR is not only important for the 
induction of a permanent proliferation arrest, but is also critically important to 
the generation of the SASP. It has been reported that inactivation of critical 
DDR mediators including NBS1, ATM and CHK2 prevents the SASP in 
response to radiation-induced senescence [67]. In addition, SASP factors 
including the chemokine IL8 and ligands of CXCR2 provide a feedback 
loop that enhances the DDR [159]. Therefore, the DDR is not an 
independent process, but rather a fully integrated branch of the other effector 
pathways that establish senescence. 
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Figure 8. DNA damage response (DDR) 
DNA double strand breaks trigger the activation of ATM which phosphorylates H2AX  
and further recruits 53BP1 at the site of DNA double strand breaks. The DDR drives 
the cell either to repair the DNA damage or halt the cell cycle, depending upon the 
extent and nature of DNA damage. 
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1.4 Hypothesis 
 
The close comparison between the factors that are up regulated during SASP 
response and in COPD draws attention to the striking similarity between the 
phenotypic state of cellular senescence and that of the pulmonary cells 
during COPD. Thus, the understanding of the phenomenon of senescence in 
COPD and the possible molecular mechanism that leads to SASP during 
senescence could also be very relevant in understanding the pathogenesis 
and inflammatory phenotype of COPD. Having this information in the 
background, two questions were asked.  
 
1. Is there an involvement of pulmonary cellular senescence in the 
pathogenesis of COPD?   
 
And if yes, 
 
2.  Does this senescence involve persistent DNA damage?  
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1.5 Aims of study 
 
 
The overall goal of this thesis was to investigate markers of senescence, 
DNA damage and repair in an in-vitro model of cigarette smoke induced 
senescence and in a cigarette smoke-induced mouse emphysema model.  
 
In particular, the aims of this thesis are: 
 
 
1. Establishment of an in-vitro model to study the effects of cigarette 
smoke induced premature senescence. 
 
 
2. To evaluate the markers of senescence, DNA damage and repair in an 
in-vitro model of cigarette smoke extract (CSE) induced premature 
cellular senescence. 
 
 
3. To evaluate the markers of senescence, DNA damage and repair in the 
murine model of cigarette smoke induced emphysema. 
 
 
4. To compare the extent of DNA damage with the development of 
emphysema in tobacco-smoke exposed mice. 
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2   Materials  
 
2.1 Reagents and chemicals 
 
Reagent  Company 
Acetic acid, glacial 99% Sigma, USA 
Acrylamide solution  Sigma, USA 
Agarose Carl Roth, Germany 
Ammonium Persulfate Sigma, USA 
β mercaptoethanol Sigma, USA 
Bromophenol Blue Roche, Germany 
Bovine serum albumin Carl Roth, Germany 
BSA solution (2mg/ml) Bio-Rad, USA 
Chloroform Carl Roth, Germany 
DAPI Invitrogen, USA 
Dimethyl sulfoxide Sigma, USA 
Digest All 2 (Trypsin) Invitrogen, USA 
DNA ladder (100bp,1Kb) Fermentas, Germany 
Ethanol absolute Carl Roth, Germany 
Ethidium Bromide Carl Roth, Germany 
Ethylenediamine- Tetracetic acid 
(EDTA) 
Carl Roth, Germany 
Fluorescence mounting medium Dako, Germany 
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Formaldehyde Carl Roth, Germany 
Glycerol Sigma, USA 
Glycine Sigma, USA 
Hydrochloric acid Carl Roth, Germany 
IQ SYBR® Green Supermix BioRad, USA 
Isopropanol Carl Roth, Germany 
JM109 competent cells Promega, USA 
Luria Broth agar Sigma, USA 
Luria Broth Sigma, USA 
Lipofectamine 2000 Invitrogen, USA 
Methanol Carl Roth, Germany 
Milk powder Carl Roth, Germany 
N,N,N´,N´-Tetramethyl-1,2-
diaminomethane (TEMED) 
Sigma, USA 
Ponceau S solution Sigma, USA 
Potassium dihydrogen phosphate Carl Roth, Germany 
Potassium phosphate monobasic Carl Roth, Germany 
Rainbow protein molecular weight 
marker 
Amersham Biosciences, USA 
RIPA lysis buffer Thermo Scientific, Germany 
Rnase Away Invitrogen , USA 
Sodium chloride Carl Roth, Germany 
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Sodium citrate tribasic trihydrate Carl Roth, Germany 
Sodium dodecyl sulfate (20% w/v) Carl Roth, Germany 
Sodim hydroxide Carl Roth, Germany 
Stripping Buffer Thermo Scientific, Germany 
TOPRO-3 Invitrogen, USA 
Tris base Sigma, USA 
Tris 1.5M (pH 8.9) Amresco, Germany 
Tris 0.5 M (pH 6.8) Amresco, Germany 
Trizol reagent Invitrogen, USA 
Tween 20  Sigma, USA 
Xtreme gene siRNA transfection 
reagent 
Roche, Germany 
Xylol Carl Roth, Germany 
 
 
2.2 Kits 
 
Names  Company 
Dc Protein assay kit BioRad, USA 
Plasmid maxi prep kit NucleoBond, Germany 
InProm-II reverse transcriptase kit Promega, USA 
In situ apoptosis Roche, Germany 
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NovaRed substrate kit Vector, USA 
Rneasy minikit Qiagen, Germany 
Supersignal west femto  Thermo Scientific,  Germany 
Senescence β-galactosidase staining 
kit 
 Cell signalling technology, Germany 
 
Agarose electrophoresis chambers Biometra, USA 
BioDoc analyzer Biometra, USA 
Cell culture incubator Heraeus, Germany 
Centrifuge Heraeus, Germany 
CFX96 tm real-time PCR detection 
system 
BioRad, USA 
Fluorescence microscope Leica, Germany  
Fujifim image Fujifilm, Japan 
Light microscope Hund, Germany 
Precellys Homogenizer PeQLab, Germany 
Microplate reader Infinite 200 TECAN , Germany 
PCR thermocycler Eppendorf, USA 
Power supply BioRad, USA 
Vacuum Pump SBG, Germany 
Water bath (cell culture) BioRad, USA 
Western blot chambers BioRad, USA 
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2.3         Cell culture medium and reagents 
 
Names  Company 
Dulbecco's phosphate buffered saline 
(DPBS) 
PAA, Germany 
Endothelial growth medium (EGM-2) Lonza, USA 
Fetal calf serum PAA, Germany 
OptiMEM-I+ GlutaMax-I Gibco, Germany 
Pencillin/Streptomycin Sigma, USA 
Smooth muscle cell medium (SmGM) Lonza, USA 
Trypsin/EDTA Sigma, USA 
 
 
2.4 Other materials 
 
Names  Company 
Cell scrapers BD Falcon, USA 
Cell culture  dishes (10cm, 3cm, 
6well, 48well,96well) 
Greiner bio-one, Germany 
Cell culture flasks (75cm2, 25cm2) Greiner bio-one, Germany 
Centrifugal protein concentrators Millipore, Germany 
Filter tips (10, 100, 1000 μl) Greiner bio-one¸ Germany 
Gel blotting paper Whatman, USA 
Microcentrifuge tubes Eppendorf, USA 
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Nitroceullulose membrane Pall Corporation, USA 
Polypropylene tubes (15ml, 50ml) Greiner bio-one, Germany 
Precellys Tubes with beads Precellys, Germany   
Real time PCR plates BioRad, USA 
Tips (10, 100, 1000 μl) Greiner bio-one, Germany 
Tissue culture chamber slides BD Falcon, USA 
 
2.5 Microscopes 
 
Names Company 
Confocal microscope Axio Imager Z.1, Germany 
Fluorescence Leica DMI 3000 B, Germany 
Fluorescence Leica DM 6000 B, Germany 
Light Microscope cell culture  Axiovert 25, Germany 
  Stereo microscope Leica MZ 16FC, Germany 
  Binocular Leica S6, Germany  
 
 
2.6 Smoke generating system 
 
Name Company 
Vacuum pump for smoke generator TSE, Germany 
Pump for removing smoke TSE, Germany 
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Smoke chamber TSE, Germany 
Millipore filter Millipore, Germany 
Cigarettes University of Kentucky, USA 
Computer program for monitoring 
smoke 
TSE, Germany 
Smoke Generator TSE, Germany 
 
2.7 Antibodies 
 
The primary and secondary antibodies used in this study are listed below: 
2.7.1 Primary antibodies 
Antigen Purpose/Dilution Isotype Supplier 
p21 WB 1:1000 
IF 1: 200 
Mouse 
monoclonal 
BD (556430) 
Germany 
53BP1 IF 1:200 Rabbit 
polyclonal 
Bethyl 
Biotech, USA 
(A300-272A-
2) 
 
Caspase - 
3/CPP32 
Mab 
 
IF 1:200 
 
Mouse 
monoclonal 
 
BD (611048) 
Germany 
Anti phospho-
Histone 
H2A.X 
(ser139)clone 
JBW301 
IF 1:200 Mouse IgG1 Millipore(05-636) 
Germany 
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HP1 IF 1:200 Rabbit Cell signaling 
(2619) 
Germany 
NF kappa B WB 1:1000 Rabbit Abcam (ab7971) 
Germany 
CD11b/CD18 IF 1:200 Mouse Millipore 
(MAB1387Z) 
Germany 
CD 34 IF 1:200 Mouse SerotecMCA 
(1825GA) 
Germany 
Von Willebrand 
factor 
IF 1:200 Human Dako (A0082) 
Germany 
CD45 PE IF 1:200 Mouse eBioscience 
(12-0451) 
Germany 
Monoclonal anti-beta 
actin 
WB-1: 5000 Mice Sigma (A5441) 
USA 
ADFP IF 1:200 Rabbit Abcam (ab52355) 
Germany 
pro SP-C polyclonal IF 1:200 Rabbit Millipore (AB3786) 
Germany 
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2.7.2 Secondary Antibodies 
 
 
Antigen Purpose/Dilution Isotype Supplier 
Alexa Fluor 488 
 
Anti-Rabbit 
ICC 1:1000 Goat IgG Invitrogen, USA 
Alexa Fluor 594 
 
Anti-Rabbit 
ICC 1: 1000 Goat IgG Invitrogen, USA 
Alexa Fluor 488 
 
Anti-Mouse 
ICC 1: 1000 Goat IgG Invitrogen, USA 
Alexa Fluor 594 
 
Anti-Mouse 
ICC 1: 1000 Goat IgG Invitrogen, USA 
Alexa Fluor 646 
 
Anti-Mouse 
ICC 1: 1000 Goat IgG Invitrogen, USA 
Anti-Rabbit IgG 
HRP-linked 
WB 1:10000 Donkey IgG GE Health care, UK 
 
Anti-Mouse IgG 
HRP-linked 
WB 1:10000 Sheep IgG GE Health care, UK 
 
 
 47 
 
2.8 Buffers and solutions 
 
The buffers and solutions used in this work are listed in Table 2.11. 
Unless specified otherwise the solutions were prepared in distilled 
and autoclaved water. Freshly prepared solutions for an application 
were not autoclaved. 
 
2.8.1 Compositions of buffers and solutions 
 
 
Buffer/Medium/Solution Compositions 
Agarose gel loading buffer 0.25% bromophenol blue [w/v] 
  0.25% xylene cyanol FF [w/v] 
 
15% Ficoll 400 [v/v] in dH2O Alkaline phosphatase (NTMT) 
buffer 
  ml NaCl (5 M) 
 510 mg MgCl2, 6H2O 
 50 µl Tween 20 
 5 ml Tris (1 M; pH 9.5) 
 
100 µl 1 M levamisole, dH2O q.s. to 50 ml Antigen retrieval buffer 0.1 M Tris/HCl buffer (pH 9.0) 
AEC stock 1 tablet AEC (20 mg) 
dissolve in 7.5 ml N,N dimethyl formamide 
store at -20°C 
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Buffer/Medium/Solution Compositions 
AEC working solution 50 µl AEC stock 
  900 µl dH2O 
 100 µl 0.5 M acetate buffer (pH 4.9) 
 
1 µl H2O2 (30%) Acetate buffer (pH 4.9) 85 g CH3COONa, 3H2O 
 900 ml dH2O 
 adjust pH with glacial acetic acid 
dH2O q.s. to 1 l 
Blocking buffer (for in situ) 5% goat serum in PBS [v/v] 
B-Block 2% BSA [w/v]  
 10% goat serum in PBST [v/v] 
 0.1% Tween 20 [v/v] 
 
store at -20°C DEPC-Water 0.01% DEPC [v/v] in dH2O 
incubate overnight at RT and then 
autoclave for 60 min. 
DNase I solution 100 mg DNase I 
dissolve in 10 ml 10 µM MgCl2 solution,      
filter and store at -20°C 
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Buffer/Medium/Solution Compositions 
  
PBS (1x)  8 g NaCl 
 0.2 g KCl 
 1.44 g Na2HPO4 
 0.24 g KH2PO4 
 dissolve in 800 ml of dH2O, adjust pH to 
 7.4 and add H2O q.s. to 1 l 
PCR buffer (10x) without MgCl2  20ml KCl (1 M) 
 4ml TrisHCl (1 M), pH 9 
 0.4ml Triton X100 
 sterile distilled water q.s. to 40 ml 
PFA in PBS (4%) 4 g PFA dissolve in 100 ml PBS (add 
few drops of NaOH). Heat at 55°C until 
PFA is dissolved. Cool and adjust the pH 
to 6-7 
PBT 0.1% Tween in PBS [v/v] 
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Buffer/Medium/Solution Compositions 
PBT/glycine 0.2% glycine in PBT [w/v] 
PT 0.3% Triton X100 in PBS [v/v] 
PBA 5% BSA [w/v] 
 
0.02% NaN3 [w/v] 
 
dissolve in PBS 
PBAT 0.3% Triton X100 in PBA [v/v] 
PBDT 0.1% DMSO and 0.1% Triton X100 in PBS 
PEM 0.1 M PIPES 
  1 mM MgSO4, 7H20 
  2 mM EGTA 
 
adjust pH to 7 RIPA buffer 2.5 ml 10% SDS in water 
 15 ml NaCl (5 M) 
  5 ml NP40 
 25 ml 10% deoxycholate in water [w/v] 
 1 ml EDTA (0.5 M) 
 25 ml Tris (1M, pH 8.0) 
 dissolve in DEPC-treated water q.s. to 
500 ml. (Not autoclaved). 
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Buffer/Medium/Solution Compositions 
SADO mix 50 ml HEPES Na (200 mM; pH 7.6) 
50 ml NaCl (1.3 M) 
5 ml KCl (300 mM) 
5 ml NaH2PO4 (100 mM) 
1 ml glucose (2 M) 
 
dissolve in 390 ml dH2O 
SSC (20x) 17.53 g NaCl 
8.82 g Na citrate 
Dissolved in 80 ml DEPC-treated water    
and adjusted the pH to 7. DEPC-treated 
water q.s. to 100 ml 
SSC/Formamide/Tween 5 ml SSC (20x) 
25 ml formamide 
50 µl Tween 20 
 
DEPC-treated water q.s. to 100 ml TBST (10x) 8 g NaCl 
0.2 g KCl 
25 ml Tris (1 M; pH 7.5) 
1 ml Tween 20 dH2O 
q.s. to 100 ml 
TAE running buffer (1x) 0.04 M Tris base 
0.002 M glacial acetic acid 
0.002 M EDTA, 2H2O 
 
dissolve in dH2O TBS 40 g NaCl 
1.8 g tris base 
dissolved in 4.5 l dH2O 
adjusted the pH 7.6 
dH2O q.s. to 5 l 
TBST 0.1% Tween 20 in TBS [v/v] 
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Buffer/Medium/Solution Compositions 
Transformation  buffer (KCM 
 
buffer) 
500 mM KCl 
 
150 mM CaCl2 
 
250 mM MgCl2 
Transfer buffer (20x) 163.2 g bicine 
  209.3 g bis Tris 
  2 g EDTA 
 
dH2O q.s. to 2 l 
Transfer buffer (1x) 250 ml 20x transfer buffer 
 1 l methanol     
dH2O q.s. to 5 l 
 
 
2.9 Antibiotics  
 
Antibiotics that were used in this study are listed below. 
Antibiotics  Working 
concentration 
liquid culture 
Working 
concentration agar 
plates 
Ampicillin 100µg/ml 100µg/ml 
Streptomycin 15µg/ml 30µg/ml 
Penicillin 20µg/ml 20µg/ml 
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3 METHODS 
 
3.1 Culture conditions 
 
For cell culture experiments cells were kept at 37 °C in humidified 
chambers containing 5 % CO2 (carbon dioxide); media were 
exchanged according to individual needs (about every 24 to 72 h). In 
case of HLF-1 cells, DMEM culture medium containing 10 % FCS 
(fetal calf serum), 1 % L-glutamine and 1 % penicillin / streptomycin 
was used.   
 
3.2  Preparation of cigarette smoke extract 
 
Cigarette smoke extract (CSE) was prepared following some 
modification from the method described by Carp and Janoff [160] 
Briefly, three 100-mm cigarette (Research Grade Cigarette, University 
of Kentucky) was combusted with a Variable Speed Pump or Water 
Jet Filter pump. The smoke was bubbled through 30 ml serum 
containing media at a speed of 1 cigarette / 2min. The prepared 
suspension was then filtered through a 0.22-μm pore filter. This 
solution was considered to be 100% CSE within 30 min of preparation 
to obtain the desired concentration.  
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Figure 9. Setup for the preparation of the cigarette smoke extract 
An in-vitro set was devised to determine if cigarette smoke indeed induced 
senescence on various cell types of interest. The cell culture media was 
bubbled with cigarette smoke. The cigarette smoke extract was freshly used 
for treating cells after 24 hours of serum starvation.  
 
 
 
The cells were treated post 24 hours of serum starvation with several 
concentrations of the prepared cigarette smoke extract as per scheme 1. 
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Scheme 1.   Cigarette smoke exposure to different cell types. 
Human lung fibroblasts and rat pulmonary arterial smooth muscle cells were 
treated by cigarette smoke extract on day 3 and day 5. Staining was 
performed on day 7. Fibrocytes were differentiated by day 7 from the PBMCs 
isolated from the human blood and later on treated with CSE/H202 on day 10 
post 24 Hours serum starvation. Second exposure was given on day 12 and 
staining was carried out on day 14. 
 
 
3.3 Cigarette smoke exposure in-vivo 
 
Wild type mice C57BL/6J were exposed to the mainstream smoke of 
3R4F cigarettes at a concentration of 140 mg particulate matter/m3 
f o r  6 h/day, 5 days/week for up to 8 months. To assure age-
matched controls, respective control groups were kept under 
identical conditions as smoke-exposed mice but without smoke 
exposure the t ime  course of COPD development was correlated 
with the markers of senescence. 
 
For alveolar morphometry and staining, lungs were fixed in chest by 
infusion of 4.5% formaldehyde solution at 22 cm H2O of inflating 
pressure via the trachea. During fixation, tracheal pressure of 12 cm 
Oxidative stress via CSE or H2O2 
For fibroblasts and smooth muscle cells              For circulating fibrocytes 
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H2O was maintained. For both alveolar and vascular morphometry, 
lungs were isolated from the chest cavity after 20 minutes and allowed 
to immerse overnight in respective fixative solution. Thus fixed lungs 
were transferred to 0.1 M phosphate buffered saline the following day. 
 
After this, the lung lobes were individually placed in histological 
cassettes and dehydrated in an automated dehydration station and 
then embedded in paraffin blocks. Staining was done on 3µm lung 
sections for alveolar staining.  
 
3.4 Removal of (residual) lungs 
 
Mice were   anesthetized   by   intraperitoneal   injection   with 
ketamine/xylazine (20µl ketamine/20µl xylazine/40µl NaCl) and 
sacrificed for investigation. Mice were k i l l ed  by an overdose o f  
i s o f l u r a n e  gas and exsanguination via the vena cava inferior. After 
sacrifice, mice were given first incision in longitudinal ventral area 
from trachea to abdomen, diaphragm was opened and tracheal area 
was cleaned. 
 
For molecular biology the trachea was incised and cannulated.  The 
thoracic cavity was opened by sternotomy, and a second cannula 
was placed into the pulmonary artery, allowing the removal of residual 
intrapulmonary blood. Then, the apex of the left ventricle was incised, 
and the lung was flushed via the pulmonary artery using 20 ml of 0.9 
% NaCl solution at a constant pressure of 25 cm H2O while being 
inflated with N2 (nitrogen) gas via the trachea at a pressure of 15 cm. 
Afterwards, the organ was removed in total and immediately frozen in 
liquid nitrogen.  
 
For alveolar morphometry, lungs were fixed in chest by infusion of 
4.5% formaldehyde solution at 20 cm H2O of inflating pressure via 
the trachea for 20 minutes. Lungs were isolated from the chest cavity 
and allowed to immerse overnight in respective fixative solution. Thus 
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fixed lungs were transferred to 0.1 M phosphate buffered saline the 
following day. 
 
After this, the lung lobes were individually placed in histological 
cassettes and dehydrated in an automated dehydration station and 
then embedded in paraffin blocks. Staining was done on 3µm lung 
sections for alveolar staining.  
 
3.5 Protein isolation from tissues 
 
100 mg of tissue was weighed and put into 500μl of RIPA buffer 
(Thermo Scientific) containing protease and phosphatase inhibitor 
cocktail. Tissues were homogenized by precellys lysing kit, followed 
by centrifugation for 30min at 4°C (13,000xg). Supernatants were 
transferred to 1,5ml tubes and directly quantified or stored at -80°C.  
 
3.6 Protein isolation from cells 
 
Protein isolation from cells was carried out using RIPA buffer (Thermo 
Scientific) containing protease and phosphatase inhibitor cocktail 
(Thermo Scientific). Media was removed from the wells, followed by a 
PBS wash. 75µl of RIPA buffer was directly added to each well of 6 
well plates and after 10min of incubation at 4°C; plates were scratched 
with cell scrapers and supernatants were put into 1,5ml tubes. The 
tubes were centrifuged for 30min at 4°C (13,000xg). Supernatants 
were transferred to 1,5ml tubes and directly quantified or stored at -
80°C. 
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3.7 Protein estimation 
 
Protein quantification was carried out using Bio-Rad DC Protein Assay 
kit. It is a colorimetric assay based on Lowry’s method involving 
reaction of protein with an alkaline copper tartrate solution and Folin 
reagent giving rise to a characteristic blue color showing absorbance 
at 750nm. Different concentrations of BSA in range of 0.125-2mg/ml 
were used as standard. Protein samples were prediluted in range of 
the standard and the absorbance was measured at 750nm using a 
micro plate reader (Tecan). Exact concentrations were calculated in 
accordance to the standards. 
 
3.8 SDS polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
SDS PAGE is carried out to separate various proteins in a sample 
according to their molecular weights for further immunoblot analysis. 
Protein samples from cells and tissues were equalized to same 
concentrations and mixed with 5X gel loading buffer at a ratio of 4:1 
and denatured at 95°C for 10min. Protein samples were loaded along 
with molecular weight marker into the wells of 7% or 10% (depending 
on protein sizes to be separated) polyacrylamide gels. Gels were run 
in vertical electrophoretic assembly using 1X running buffer at 100-
120V for 2-3 hrs. Buffers used are as follows:  
 
5X gel loading buffer 
components 
Final concentration 
Tris-HCl (2M, pH-6.8) 375mM 
SDS 10% (w/v) 
Glycerol 50%(v/v) 
β-Mercaptoethanol 12.5%(v/v) 
Bromophenol Blue 0.02%(w/v) 
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1X SDS Running buffer 
components 
Final concentration 
Tris  25mM 
Glycine 250mM 
SDS 10% (w/v) 0.1%(w/v) 
 
Stacking gel (5%) 
Gel Component  Final concentration 
Tris-HCl (0.5M, pH-6.8) 125mM 
Acrylamide/Bis-acrylamide 
40% (w/v) 
6% 
SDS 10% (w/v) 0.10% 
APS 10% (w/v) 0.05% 
TEMED 0.10% 
Water up to the final volume  
 
Resolving gel 
Gel component Percentage of gel 
 
 8% 10%          12% 
Tris-HCl (1.5M, pH-8.8) 375mM 375mM  375mM 
Acrylamide/Bis-acrylamide 
40% (w/v) 
10% 10%          12% 
SDS 10% (w/v) 0.10% 0.10%      0.10% 
APS 10% (w/v) 0.05% 0.05%      0.05% 
TEMED 0.10% 0.10%      0.10% 
Water up to the final volume   
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3.9 Immunoblotting  
 
Proteins separated on gel were transferred to a nitrocellulose 
membrane by electrophoretic transfer. The transfer was carried out for 
1hr at 100V in transfer buffer. 
 
Blotting buffer components Final concentration 
Tris 25mM 
Glycine 192mM 
Methanol 20%(v/v) 
  
After the transfer, membranes were removed and blocked in blocking 
buffer for 1hr on shaker at RT, followed by overnight incubation in 
primary antibodies diluted in blocking buffer (for dilutions, Appendix 
Table 2) at 4°C.  Following day, membranes were washed 3 times for 
10min with 1xTBST buffer and subsequently incubated in secondary 
HRP-conjugated antibodies diluted in blocking buffer for 1hr at RT. 
After 1hr of incubation, membranes were washed thrice for 10min in 
1x TBST and incubated with ECL substrate (Thermo Scientific) in the 
Image reader (Fujifilm) to detect the signal. The time of exposure was 
determined on the basis of signal intensity.   
 
1xTBST (1xTBS, 0.1% (v/v) Tween 20) 
Tris buffer saline (TBS) components              Final  Concentration 
Tris 20mM                              20mM 
Sodium                              137mM 
Tween                              0.1% 
HCl                                                                              To set the pH 
Water                                                               up to the final volume 
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Blocking buffer (5% non-fat dry milk powder in 1xTBST) 
In order to reprobe the membranes for housekeeping genes, 
membranes were stripped in a stripping buffer (Thermo Scientific) for 
30min at 37°C, washed and incubated with the primary antibodies. 
 
Densitometry analysis of the immuno-blots 
Western blots were quantified using the multi gauge software 
(Fujifilm). Expression was quantified using bands intensity values (in 
arbitrary units) which were normalized to the housekeeping gene (β-
actin). 
 
3.10  Transfection with over expression plasmid 
 
Transfection refers to the process of introducing foreign DNA or RNA 
into mammalian cells. In this study, lipofection was used as the 
method of transfection, lipofection refers to use of synthetic cationic 
lipid to facilitate the delivery of DNA into the cells. These cationic lipids 
tend to form liposomes in aqueous solution. Liposomes, thus formed, 
interact with negatively charged DNA to form lipid-DNA complexes. 
The complex fuses with the plasma membrane of cells, resulting in the 
uptake of DNA and further expression of the gene carried by the 
plasmid DNA. 
HEK 293 cells were cultured to 70-80% confluence in 6well plates (for 
protein isolation) or chamber slides (for immunofluorescence). Plasmid 
and lipofectamine were diluted in antibiotic free opti-MEM medium and 
mixed within 5 min at ratio of 1:2 (DNA in μg to transfection reagent in 
μl). The mixture was incubated at RT for 30min and added to the cells 
which were cultured in antibiotic free transfection medium (opti-MEM 
medium + basal growth medium with 0.1% FCS). After 5hrs, medium 
was changed to the normal growth medium up to 48hrs, followed by 
protein isolation or immunofluorescence staining. 
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3.11 Immunohistochemistry  
 
4μm thick sections were cut from paraffin embedded lung tissues. 
Sections were incubated at 65°C for 20min, followed by 
deparaffinization in xylene and rehydration in series of grade-
decreasing ethanol solutions. Sections were washed with PBS and 
incubated in boiling 10mM citrate buffer for 8min at 630watt in 
microwave for antigen retrieval. When needed, antigen retrieval was 
carried out by using 0.25% trypsin for 10min at 37°C. After blocking 
endogenous peroxidases activity by treatment with 15% hydrogen 
peroxide for 20min, Nova RED horseradish peroxidase (HRP)-
substrate kit was used for immunohistochemical staining according to 
the manufacturer’s instructions. Sections were kept in serum blocking 
for 1hr, followed by overnight incubation with primary antibody at 4°C. 
After washing with PBS, sections were incubated with biotinylated 
secondary antibody for 10min, followed by again a PBS wash and 
incubation with streptavidin conjugated HRP for 5min. Sections were 
washed and color development was carried out using a 
substrate/chromogenic mixture, followed by counterstaining with 
hematoxylin. Stained sections were examined under Leica DM 2500 
microscope using Leica Q Win imaging software 
 
3.12  Senescence associated β-galactosidase cell 
staining 
 
The growth media from the cells was removed. The plate was then 
rinsed once with 1X PBS (2 ml for a 35 mm well). 1 ml of 1X fixative 
solution to each 35 mm well was added. The cells were then allowed 
to fix for 10-15 minutes at room temperature. The plate was then 
rinsed two times with 1X PBS (2 ml for a 35 mm well). 1 ml of the b-
galactosidase staining solution to each 35 mm well was added and the 
plate was incubated at 37°C overnight in a dry incubator (no CO2). 
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While the b-galactosidase staining solution was still on the plate, the 
cells were checked under a microscope (200X total magnification) for 
the development of blue color. For long-term storage of the plates, the 
b-galactosidase staining was removed and the cells were overlaid with 
70% glycerol and stored at 4°C. 
 
 
3.13  Senescence detection by fluorescence  
 
The ImaGene Green C12 FDG lac-Z Gene Expression Kit (I-2904) 
was used for fluorescence staining of senescent cells as per the 
manufacturer’s protocol. 
Cells were grown on coverslips inside a culture dish with appropriate 
cell culture medium to the desired confluency. The medium was 
removed from the dish and the cells were covered with pre-warmed 33 
µM substrate containing culture medium. The cells are then incubated 
for 20-60 minutes under desired conditions. The coverslips then can 
be removed and examined in the fluorescence microscope. 
 
3.14  Statistical analysis 
 
All data are expressed as mean ± standard error of mean (SEM). 
Statistical comparisons of samples were performed by Student's t test 
for comparing two groups or by one-way ANOVA followed by the 
Newman-Keuls post-hoc test for multiple comparisons. Difference with 
p<0.05 between groups was considered significant. 
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4  RESULTS 
Classically, COPD primarily has been considered a lung disease that is mainly 
caused by cigarette smoking. However, COPD has important manifestations 
beyond the lungs, the so-called systemic effects. These include unintentional 
weight loss, skeletal muscle dysfunction, and an increased risk of 
cardiovascular disease, osteoporosis, and depression, among others. Low-
grade, chronic systemic inflammation is one of the key mechanisms underlying 
these systemic effects. Because these extra-pulmonary manifestations of 
COPD are common and/or may have significant implications for the patient 
wellbeing and prognosis both lung resident cell types as well as the systemic 
cells are believed to be involved in the pathogenesis of or response to COPD. 
It was hence an aim to investigate lung resident cells and systemic cells. It had 
been hypothesized that the primary cause of increased inflammation and 
pathogenesis is the onset of DNA damage and premature senescence upon 
exposure to cigarette smoke. 
 
4.1 Characterization of lung resident and systemic cells.  
Isolation and characterization of different lung resident and systemic cells 
were carried out with the aim to decipher the markers of cellular senescence 
and DNA damage upon treatment with cigarette smoke exposure over them. 
Cell types that were investigated further for our studies were namely human 
lung fibroblasts and circulating fibrocytes from human blood and are shown in 
Figure 10.  
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Figure 10. Characterization of lung resident fibroblasts and systemic human circulating 
fibrocytes.  
(A). Representative images of primary lung fibroblasts characterized by spindle shape 
morphology in bright field (B). Circulating fibrocytes were isolated from the PBMCs and 
characterized by the presence of CD 11b and alpha smooth muscle actin (α-SMA). 
.  
 
A B
DAPI 
α-SMA 
CD11b 
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4.2 Cigarette smoke extract exposure induced cellular 
senescence in-vitro 
 
Morphologic changes are characteristic features of the senescent phenotype 
that occur at both the cellular and organism level. Senescent cells showed 
morphologically flattened and enlarged cell shapes. Human lung fibroblasts 
were exposed to cigarette smoke exposure in-vitro as described in Scheme 1 
in the methods section. Cigarette smoke exposure in-vitro could induce 
characteristic morphological senescent phenotype as shown in Figure 11. 
 
 
Figure 11. Morphological changes in Human Lung Fibroblasts 1 (HLF-1) cells after 
chronic exposure to cigarette smoke in-vitro. 
HLF-1 cells were exposed to 1 % cigarette smoke and their morphology was examined 
through bright field microscopy. The morphological changes upon CSE treatment 
resembled closely to senescent phenotype. (A). Normal HLF-1  cells as control. (B). 
HLF-1 cells treated with 1% CSE showed flattened and enlarged phenotype resembling 
senescent phenotype. 
 
 
 
 
 
 
A B 
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Senescence-associated (beta)-galactosidase is widely used as a biomarker of 
senescence. The pH 6 β-galactosidase activity detected in senescent cells 
can be attributed to a rise in the level of the classic lysosomal enzyme. 
Furthermore, there are evidences that this is a consequence of an increase in 
lysosomal mass in senescent cells [161]. β-D-galactosidase is an eukaryotic 
lysosomal hydrolase.  It acts by cleaving β-linked terminal galactosyl residues 
from many substrates like the glycoproteins, gangliosides, glycosaminoglycan 
and many other artificial substrates. The β-D-galactosidase has an optimum 
pH 4 for its activity which is closer to the natural pH of the lysosome. 
Lysosomal β-galactosidase activity can be detected in situ in most mammalian 
cells by means of a cytochemical assay, normally carried out at pH 4, using 
the chromogenic substrate 5-bromo-4-chloro-3-indolyl β-D-galactopyranoside 
(X-Gal). Dimri et al. (1995) described a pH 6 β-galactosidase activity, which 
was found specifically in senescent human fibroblast cultures, but not in 
quiescent or terminally differentiated cells. Furthermore, this pH 6.0 activity 
enabled identification of senescent fibroblasts and keratinocytes in biopsies of 
aged human skin, and subsequently became known as senescence 
associated β-galactosidase (SA-β-galactosidase). 
 
Different cell types were exposed to CSE or H2O2 (as described in scheme 1). 
A sub lethal dose of CSE could indeed induce senescence, as evident by 
senescence associated β-galactosidase activity. Hydrogen peroxide was used 
as a positive control. Senescence was detected by the presence of beta 
galactosidase activity at pH-6 (Figure 12).   
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Figure 12. Increased senescence upon cigarette smoke treatment Human Lung 
Fibroblasts 1 cells (HLF-1). 
HLF-1 cells were treated with different doses of cigarette smoke extract (CSE) leading 
to senescence. H2O2 treatment was done as a positive control. Senescence was 
detected by β-galactosidase activity using x-gal. Higher β-galactosidase activity 
indicates higher senescence. Representative bright field images of (A). Control HLF-1 
cells (B). HLF-1 cells treated with 300uM H
2
O
2
 (C). HLF-1 cells treated with 1% CSE (D). 
HLF-1 cells treated with 2% CSE (E). HLF-1 cells treated with 3%CSE (F). HLF-1 cells 
treated with 5% CSE (G). Quantitative analysis of the senescescent cells were 
performed by counting blue cells in 10 random fields.  
 
 
G 
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In addition, the modified version of a cell permeable fluorescent β-
galactosidase substrate, fluorescein di-b-D-galactopyranoside (FDG), supplied 
by Molecular Probes as ImaGene Green™ C12FDG lacZ Gene Expression Kit 
(I-2904) was used to assess senescence (Figure 13). Once fluorescein di-b-
D-galactopyranoside (FDG) reacts with the β-galactosidase, it turns into a 
fluroscencent compound which is not further permeable to the cells. Hence the 
substrate could be used as a marker of β-galactosidase activity at pH 6 
indicative of cellular senescence.  
 
β-D- galactosidase activity at pH 6 was found to be increased with C12FDG 
indicative of increased cellular senescence after chronic exposure to cigarette 
smoke extract in-vitro. 
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Figure 13. Increased senescence upon cigarette smoke treatment in Human Lung 
Fibroblasts (HLF-1). 
HLF-1 cells were treated with different doses of H2O2 and cigarette smoke extracts 
(CSE). Senescence induced by treating the cells by H2O2 was used as a positive 
control. Senescence was detected by β-galactosidase activity using a fluorescent dye 
C12 FDG. Higher β-galactosidase activity indicates higher fluorescence. Induction of 
senescence was found to be concentration dependent.  
 
A & D. HLF-1 cells untreated as control. B & E. HLF-1 cells treated with 100µM H2O2.  
C & F. HLF-1 cells treated with 200µM H2O2. G & J. HLF-1 cells treated with 300µM 
H2O2.  H & K. HLF-1 cells treated with 1% CSE.  I & L. HLF-1 cells treated with 5%CSE  
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While the human lung fibroblasts underwent senescence upon CSE treatment, 
the human circulating fibrocytes rather proliferated and were resistant to CSE 
challenge as shown in the Figure 14 below.  
 
 
 
 
 
Figure 14. Circulating fibrocytes did not undergo increased senescence upon CSE 
treatment 
Circulating fibrocytes were isolated from human blood and treated with hydrogen 
peroxide and different doses of cigarette smoke extract. Senescence was detected by 
β-galactosidase activity using C12FDG (in green). Higher β-galactosidase activity 
indicated higher senescence. There was no increase in senescence upon CSE 
treatment with reference to the controls.  
A & D. Representative images of control circulating fibrocytes untreated.  
B & E. Representative images of circulating fibrocytes treated with 500uM of 
hydrogen peroxide.  
C & F. Representative images of circulating fibrocytes treated with 3% Cigarette 
smoke extract.  
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4.3 Cigarette smoke extract exposure lead to increased 
hetero-chromatinization 
 
Senescence leads to hetero-chromatinization within the nucleus and this also 
may serve as a marker of senescence. Cells treated with cigarette smoke 
extract at sub lethal doses showed an increased amount of nuclear DNA 
domains stained densely by DAPI. This represents increased 
heterochromatinization inside their nucleus, so called senescence associated 
heterochromatin foci (SAHF) (Figure 15).  
 
 
 
 
 
 
 
 
Figure 15. CSE lead to the formation of senescence associated heterochromatin foci 
Cells were treated with CSE and observed under light microscope for nucleus with 
condensed chromatin foci indicative of increased heterochromatinization (SAHF) with 
DAPI staining (blue).   
A. Represents a normal nucleus with diffuse DAPI (blue) staining.  
B. Represents nucleus with DAPI (blue) punctate staining indicative of the formation 
of SAHF upon 1% CSE treatment. 
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4.4 Senescence induced by cigarette smoke extract exposure 
in-vitro involves accumulation of DNA double strand 
breaks 
 
Keeping in mind the chronic inflammation in COPD, it was obvious to think that 
pulmonary cellular senescence, if any in COPD, must involve factors that lead 
to a SASP response. SASP occurs only when senescence involves factors 
that lead to DNA damage. Cigarette smoke exposure is the primary cause of 
COPD. Hence, investigations were carried out to check if cigarette smoke 
extract in-vitro caused DNA damage.  
Nuclear  Specific marker of DNA double strand break (dsb), 53 BP1 foci were 
checked upon by immunofluorescence microscopy. 53BP1 forms foci on the 
site of DNA double strand breaks and is a specific marker for DNA dsb. 53 
BP1 was found to form DNA damage foci in the cells that were treated with 
cigarette smoke extract. p21, which is a maker of cell cycle arrest, was 
localized in parallel. Both 53BP1 and p21 were found to be upregulated 
(Figure 16).  
What was interesting to note, was that not all the cells that were positive for 53 
BP1 were positive for p21, but all the cells positive for p21 were positive for 
53BP1. This indicated that not all the cells that undergo DNA damage 
necessarily undergo cell cycle arrest, but only those cells, in which the DNA 
damage has been persistent and accumulated beyond repair, decide to halt. 
It was also noted that a higher dose of CSE not necessarily lead to formation 
of higher DNA damage induced 53 BP1 foci. A higher dose of CSE rather 
induced apoptosis (Figure 17). 
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Figure 16. Human Lung Fibroblast-1 (HLF-1) cells treated with CSE display nuclei 
with 53 BP1 positive DNA damage foci indicative of DNA double strand breaks and 
higher expression of p21 indicative of cell cycle arrest.  
A. Control HLF-1 cells stained with DAPI (blue) B. Control cells stained with 53BP1 
(green). C. Control HLF-1 cells stained with p21 (red) D. Represents a merged image of 
A, B and C. E. s HLF-1 cells treated with 1% CSE stained with DAPI (blue) F. HLF-1 cells 
treated with 1% CSE stained with 53BP1 (green) G. HLF-1 cells treated with 1% CSE 
stained with p21 (red) H.  Merged image of E, F and G. I. Quantification of 53 BP1 and 
p21 positive cells in control and CSE treated cells.  
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4.5 Treatment with increased doses of CSE lead to apoptosis 
 
It was also noted that while a lower dose of CSE lead to the formation of 53 
BP1 foci, the higher dose lead to activation of Caspase 3 (Figure 17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Chronic exposure to lower concentration of cigarette smoke 
extract lead to accumulation of the DNA damage while higher 
concentration of CSE lead to apoptosis in Human Lung Fibroblast -1 (HLF-1) 
cells.   
HLF-1 cells were cultured and treated with different dose of CSE.A. HLF-1 cells 
stained with DAPI as control B. HLF-1 cells with exposure to lower dose of CSE 
(1%) having DNA double strand break inside the nucleus with recruitment of 
53 BP1 positive foci (green dots) C. HLF-1 cells exposed to higher dose of CSE 
(3%) and D. 5% lead to apoptosis as evident from activated Caspase 3 
(CPP32) staining in red. 
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4.6 Activation ofH2A.X and DNA damage foci in-vitro 
 
Activation of a DNA damage response leads to the formation of DNA damage 
foci comprising of the activated H2A.X (gamma-H2A.X). Double-strand breaks 
(DSBs) are the most deleterious DNA lesions, which, if left unrepaired, may 
have severe consequences for cell survival. Persistent DNA strand breaks are 
the major trigger of cellular senescence. This is because DNA DSBs may lead 
to chromosome aberrations, genomic instability, or cell death.  
DSB induction could occur due to various physical, chemical, and biological 
factors. Cells respond to DNA damage by activating the so-called DNA 
damage response (DDR), a complex molecular mechanism developed to 
detect and repair DNA damage. The formation of DSBs triggers activation of 
many factors, including phosphorylation of the histone variant H2AX. This 
leads to the formation of gamma H2AX foci within the nucleus of the cell. 
Phosphorylation of H2AX plays a key role in DDR and is required for the 
assembly of DNA repair proteins at the sites of DNA damage as well as for 
activation of checkpoints proteins which arrest the cell cycle progression. 
Formation of gamma H2AX foci can be used as a specific marker of DNA 
double strand breaks.  
Hence we stained for gamma-H2A.X. Significant gamma H2AX foci formation 
were observed in the CSE treated cells ( Figure 18). 
 
 
 
 
 
 
 
 
 77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 18. Human Lung Fibroblast-1   (HLF-1) cells treated with cigarette smoke 
extract shows formation of gamma H2AX positive DNA damage foci indicative of 
DNA double strand breaks and higher expression of HP1 indicative of 
heterochromatin formation.  
HLF-1 cells were cultured and treated with different dose of CSE A.  Control HLF-1 cells 
stained with DAPI in blue B. Control cells stained with H2AX in red. C. Control HLF-1 
cells stained with HP1 in green D. Merged image of A, B and C. E. HLF-1 cells treated 
with 1% CSE stained with DAPI in blue F. HLF-1 cells treated with 1% CSE stained with 
H2AX in red G. HLF-1 cells treated with 1% CSE stained with HP1 in green H. Merged 
image of E, F and G. I. Quantification of H2AX and HP1 positive cells in control and CSE 
treated cells.  
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4.7 Mouse model of pulmonary emphysema 
 
There are no animal models available which exactly mimic chronic obstructive 
pulmonary disease. Mice, exposed to cigarette smoke exposure chronically 
over a long period of time, resemble a valid animal model to study 
emphysema pathophysiology [142]. However, the model does not exhibit 
much chronic bronchitis; hence calling it a model of COPD may not be precise. 
We utilized this animal model in which mice were exposed to cigarette smoke 
for different times (2, 6 or 8 months) and lung sections were examined for 
formation of emphysema (Figure 19).  
 
 
 
 
 
 
 
 
A. Lung sections from 8 month old control mice stained with DAPI B. Differential 
Interference Contrast (DIC) image of lung sections from 8 month old control mice. C. 
Lung sections from 8 month smoke exposed mice, stained with DAPI D. DIC image of 
Lung sections from 8 month smoke exposed mice E. Lung sections from 6 month old 
control mice stained with DAPI F. DIC image of lung sections from 6 month old control 
mice G. Lung sections from 6 month smoke exposed mice stained with DAPI H. 
DIC image of lung sections from 8 month smoke exposed mice. 
 
 
Figure 19. Mice were exposed to cigarette smoke upto 8 months and the lung 
paraffin sections (5𝝁M) were viewed to characterize emphysema 
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4.8 Gamma H2AX foci was found to be upregulated in 
cigarette smoke exposed mice model of emphysema 
 
To correlate the in-vitro findings to that in the in-vivo model, lung sections from 
mice with chronic cigarette smoke exposure were also examined for gamma 
H2AX as shown in Figure 20.  Gamma H2AX was significantly upregulated in 
lung sections from mice exposed to cigarette smoke.  
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Mice were exposed to cigarette smoke for 2, 6 and 8 months respectively and the lung 
paraffin sections (5 M) were stained with γ H2AX. The sections were examined by 
confocal microcopy for DNA damage. A. Lung paraffin sections from 2 month control 
mouse, stained with γ H2AX (red) B. Lung paraffin sections from 2 month control 
mouse, stained with DAPI (blue). C. Lung paraffin sections from mouse exposed to 
cigarette smoke for 2 month, stained with γ H2AX (red). D. Lung paraffin sections from 
2 month control mice, stained with DAPI (blue). E. Lung paraffin sections from 6 
month control mice, stained with γ H2AX. F. Lung paraffin sections from 6 month 
control mice, stained with DAPI (blue). G. Lung paraffin sections from mice exposed to 
CS for 6 month, stained with γ H2AX (red). 
 
Figure 20. Increased  γH2AX foci indicating DNA damage-repair foci in mice lungs 
upon cigarette smoke exposure.  
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H.  Lung paraffin sections from mice exposed to cigarette smoke for 6 month smoked 
lung paraffin sections, stained with DAPI (blue). I.   Lung paraffin sections from 6 
month control stained with γ H2AX (red). J.   Lung paraffin sections from 6 month 
control stained with DAPI (blue). K. Lung paraffin sections from mice exposed to 
cigarette smoke for 8 month stained with γ H2AX (red). L.  Lung paraffin sections from 
mice exposed to cigarette smoke for 8 month stained with DAPI (blue). M. Basic 
fluorescence Intensity quantification of γ H2AX with ImageJ (n = 4, mean ± SEM). 
 
 
 
 
4.9 53BP1 foci and p21 was found to be upregulated in 
cigarette smoke exposed mice model of emphysema 
 
Antibodies for 53 BP1 and p21 did not work well enough on the lung paraffin 
sections. Hence lung cryo sections from the aged matched control and smoke 
exposed mice were prepared. The lungs sections revealed that 53BP1 foci 
were upregulated in the cigarette smoke exposed mice. Expression of p21 
revealed that p21 was significantly upregulated upon exposure to cigarette 
smoke in our in-vivo model. 
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Figure 21.  Increased 53BP1 indicating DNA double strand breaks in mice lungs upon 
cigarette smoke exposure.  
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Mice were exposed to cigarette smoke for 2, 6 and 8 months respectively and the lung 
cryo sections (5 M) were examined for DNA double strand breaks by 53BP1 and cell 
cycle arrest with p21. 
 A.  Lung cryo sections from mice exposed to cigarette smoke for 8 months stained 
with 53BP1 (green). B .  Lung cryo sections from mice exposed to cigarette smoke for 
8 months with p21 (red). C. Lung cryo sections from mice exposed to cigarette smoke 
for 8 months with DAPI D.  Lung cryo sections from 8 month old mice stained with 
53BP1. E. Lung cryo sections from 8 month old mice stained with p21. F. Lung cryo 
sections from 8 month old mice stained with DAPI. G. Lung cryo sections from mice 
exposed to cigarette smoke for 6 months stained with 53BP1. H. Lung cryo sections 
from mice exposed to cigarette smoke for 6 months stained with p21. I. Lung cryo 
sections from mice exposed to cigarette smoke for 6 month stained with DAPI. J. Lung 
cryo sections from 6 month old mice stained with 53BP1. K. Lung cryo sections from 6 
month old mice stained with p21. L. Lung cryo sections from 6 month old mice stained  
with DAPI blue. M. Lung cryo sections from mice exposed to cigarette smoke for 2 
months stained with 53BP1. N. Lung cryo sections from mice exposed to cigarette 
smoke for 2 months stained with p21. O. Lung cryo sections from mice exposed to 
cigarette smoke for 2 months stained with DAPI. P. Lung cryo sections from 2 month 
old mice stained with 53BP1 (green). Q. Lung cryo sections from 2 month old mice 
stained with p21 (red) R. Lung cryo sections from 2 month old mice stained with DAPI. 
S. Represents quantification of 53 BP1 foci (n =5, mean ± SEM). 
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4.10  Increased inflammation in the lungs upon smoke 
exposure 
 
Western blot analysis of the protein isolated from the lung homogenate of mice 
exposed to cigarette smoke and their aged matched controls that were not 
exposed to cigarette smoke revealed that cigarette smoke exposure induces 
inflammation as evident from increased NF-Kappa B expression (Figure 22).  
 
 
  
Figure 22.  Increased NF kappa B expression in mouse lungs upon cigarette smoke 
exposure. 
Mice (n=6 in each group) were exposed to cigarette smoke for 2 months and the lung 
homogenates were examined for the expression of NF kappa B through western 
blotting. 22. A. Western blots indicating the upregulation of NF kappa B in the lung 
homogenate of cigarette smoke exposed mice (SM) compared to the aged match 
control (Ct) mice 22.B. Quantification of the western blots by densitometry analysis 
  
N1   N2   N3   N4    N5   N6  N1   N2   N3   N4    N5   N6 
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4.11 Increased cell cycle arrest (p21) in mouse lungs upon 
smoke exposure 
 
 
Figure 23. Increased p21 expression in mice lungs upon cigarette smoke exposure. 
 
Mice (n=6 each group) were exposed to cigarette smoke for 8 months and the lung 
homogenate were examined for the expression of p21 through western blotting. 
 23. A. Western blots indicating the upregulation of p21 in the lung homogenate of 
cigarette smoke exposed mice(SM) compared to their aged match control mice (C).  
23. B. Quantification of the western blots by densitometry analysis 
 
 
 
 
 
23. B  
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4.12  Short hairpin RNA (ShRNA) for ATM blocks IL6 release in 
CSE induced senescent cells 
 
RNA interference is a powerful technology that allows to suppress gene 
expression [162]. However, in most mammalian cells this provokes a strong 
cytotoxic response [163]. This non-specific side effect could be bypassed by 
using synthetic short (21- to 22-nucleotide) interfering RNAs, or short hairpin 
RNA, which can mediate strong and specific suppression of gene expression.  
 
 
Figure 24. Strategy to block ATM with shRNA to block SASP response 
The figure explains a strategy to knock down ATM to observe any changes in SASP 
response. ATM is central to DNA damage response. If the SASP response in senescence 
indeed is due to the DDR response, knocking down the central player of the DDR 
response would inhibit SASP response.  
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Since the first application of RNA interference (RNAi) in mammalian cells, the 
expression of short hairpin RNAs (shRNAs) for targeted gene silencing has 
become a benchmark technology. We employed it to suppress the central key 
player of the DDR response pathway, ATM with the aim to investigate if 
inflammation induced by cigarette smoke in-vitro is indeed caused by the DDR 
signalling and not senescence per se.  
Short hairpin RNA or shRNA against ATM were used to knock down ATM in 
HEK 293 cells and IL-6 release was checked upon subsequently. IL-6 release 
was diminished upon CSE treatment by blocking ATM (Figure. 25). 
 
 
Figure 25. shATM suppresses IL6 release in CSE induced  senescent cells in-vitro 
HEK 293 cells were transfected with shRNA for ATM and scrambled control. These cells 
were treated with 1 % CSE and later stained for IL-6.  While the control cells show no 
IL6 release (A), the CSE treated HEK293 cells and CSE treated HEK 293 cells 
transfected with the scramble showed IL-6 release (B &C). The shRNA for ATM 
suppressed the release of IL-6 upon CSE treatment. 
 
 
IL6 
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5 Discussion 
 
Researchers in the past have described several theories for the pathogenesis 
of COPD [1, 164-167]. Laurell and Eriksson described the association 
between α-1 protease inhibitor (PI) deficiency and pulmonary emphysema 
[168] Further experimental studies conducted by Gross and others 
demonstrated that infusion of elastolytic enzymes into the lungs induced 
emphysema[169-171]. In contrast, a proteolytic enzyme that does not degrade 
elastin could not induce emphysema. These observations led to the protease-
antiprotease theory of emphysema. The initial attention largely focused on α-1 
protease inhibitor and neutrophil elastase. Later, other enzymes and inhibitors 
were believed to play an important role. Numerous serine proteases in 
addition to leukocyte elastase, including chymotrypsin and proteinase 3, have 
elastolytic activity and may contribute to the development of emphysema 
[172]. Similarly it was observed that metalloproteases and cysteine proteases 
may also have elastolytic activity as they were found in the lung of COPD 
patients and believed to contribute in the development of emphysema[173]. 
Further, inhibitors of these enzymes are also present in the normal lung, thus 
expanding the concept of protease-antiprotease balance. 
Variations in antioxidants may also predispose one to COPD. There is 
considerable evidence for increased oxidative stress in COPD [174-
176]. Oxidative stress is derived from cigarette smoke and from inflammation 
caused by the activation of macrophages and neutrophils. Epidemiological 
evidence suggests that reduced dietary intake of antioxidants may also be a 
factor causing COPD. The population surveys have linked a low dietary intake 
of the antioxidant ascorbic acid with declining lung function [177, 178].  
 The increased oxidative stress in the airways of COPD patients may play an 
important pathophysiological role in the disease by amplifying the 
inflammatory response in COPD. This may reflect the activation of NF-κB and 
activator protein-1, which then induce a neutrophilic inflammation via 
increased expression of IL-8 and CXC chemokines, TNF-α and MMP-9. 
Oxidative stress may therefore serve to amplify the ongoing chronic 
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inflammatory response in COPD and may be an important mechanism leading 
to increased inflammation during acute exacerbations.  
 
5.1 COPD a disease of elderly 
 
Inspite of the numerous scientific findings supportive of the various 
hypotheses for pathogenesis of COPD, there is still a fundamental lack of 
knowledge about the molecular mechanisms underlying the causes of COPD.  
With the exception of those who have homozygous alpha-1-antitrypsin 
deficiency, in the vast majority of COPD patients there is no in-vivo evidence 
of significant protease–antiprotease imbalance at the cellular or organ level, 
indicating that there must be some other processes additionally in play. It is 
important to note that the prevalence of COPD increases exponentially with 
aging. Before 40 years of age COPD is extremely rare, but by 70 years of age 
the prevalence is as high as 30%[179, 180], even among ex-smokers or 
lifetime nonsmokers, indicating a strong link between aging and COPD. 
Patients diagnosed with chronic obstructive pulmonary disease have limited 
therapeutic options.  
The existing therapies are inadequate because no causative treatments exists 
that could hold disease progression. Airflow limitation, measured by reduced 
FEV1, progresses very slowly over several decades. So most patients with 
symptomatic COPD are in middle age or are elderly. Thus, the prevalence of 
COPD is at least partly also an age dependent phenomenon. The prevalence 
of the disease in elderly suggests an intimate relationship between the 
pathogenesis of COPD and aging. 
 
5.2 Aging hypothesis of COPD 
 
Aging is characterized as a condition that basically satisfy four principles: it is 
intrinsic (gene dependent), universal, progressive, and usually detrimental to 
the host[181]. Aging lung results in both structural and functional lung 
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changes that comply with these four principles in healthy subjects [182].  
Cellular senescence is a vital biological state that implements a halt on the 
replicative capacity of any impaired or damaged cell via a network of 
programmed processes. As a result, senescence has evolved as a potent 
barrier to tumorigenesis and contributes to other physiological processes such 
as aging and wound healing.  
 
 
 
Figure 26. Hypothesis of development of COPD by an accelerating lung aging [183].  
Aging is defined as the progressive decline of homeostasis, and this is the result of 
failure of organ maintenance from DNA damage, oxidative stress, and telomere 
shortening. During aging, pulmonary function deteriorates progressively and 
pulmonary inflammation is increased with structural changes in the lung parenchyma 
and small airways. Environmental exposure, for example cigarette smoke, may 
accelerate aging-dependent defective lung function [183]. 
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Several clinical observations support the hypothesis, that accelerated aging 
may play a role in the pathogenesis of COPD. First, lung function starts to 
decline in healthy individuals over 30 years of age. This is associated with 
several structural changes, such as progressive distal air space enlargement, 
with loss in the gas exchange surface area and the supporting alveolar 
attachments in the peripheral airways[182]. It is postulated that smoking 
induces elastin fiber degradation and matrix remodeling in the lungs similar to 
that which occurs with aging in the skin, resulting in skin wrinkling[184-186]. It 
has also been shown in the past, that an in-vitro exposure of human epithelial 
cells to cigarette smoke extract results in an increased expression of 
senescence-associated [beta]-galactosidase (SA-[beta]-gal), a marker of 
cellular senescence[77]. Further, it has been shown that senescence marker 
protein-30 (SMP30) is a multifunctional protein which provides protection 
against deleterious changes related to aging. Transgenic mice with deficiency 
in SMP30 (i.e. SMP30 knockout mice) contain lungs that demonstrate 
significantly larger mean linear intercept than wild-type mice when exposed to 
cigarette smoke, suggesting more emphysematous changes in the lungs[187] 
Mice with deficiencies in the klotho gene have short life span and age related 
disorders. Klotho gene knockout mice develop emphysematous changes in 
the lungs following normal development [188]. 
Several striking similarities in the profile of aging lung to that of COPD lung 
suggest that accelerated aging could be one of the root causes of COPD. It 
has been believed, that premature cellular senescence contributes to 
accelerate organismal aging. Furthermore, reviewing the similarities between 
the secretory profiles of DNA damage induced senescent cells and that of 
COPD, a premature cellular senescence hypothesis may hold value for the 
pathogenesis of COPD.  
 
Evidence of premature cellular senescence in COPD patients had been 
reported by a few groups [189, 190], however a systematic study of an animal 
model of emphysema in a time dependent manner for assessing the 
senescence hypothesis had been missing. Moreover, it remained elusive 
whether the pulmonary senescence that occurs in COPD could be linked to 
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DNA damage, possibly caused by the oxidative stress due to the cigarette 
smoke.  
 
 
5.3 COPD involves more than just lungs  
 
Many patients with chronic obstructive pulmonary disease (COPD) suffer from 
exercise intolerance. In about 40% of the patients exercise capacity is limited 
by alterations in skeletal muscle rather than pulmonary problems [191]. 
Increasing evidence suggests that COPD is a complex systemic disease 
involving more than just the airways and lungs [192]. COPD patients have high 
rates of comorbidities. These include cardiovascular disease and metabolic 
disorders which have been linked to the systemic component of COPD 
inflammation [190]. COPD does not just affect the lung resident cells but 
systemic cells as well. Data from the past shows evidence for increased 
systemic markers of oxidative stress in patients with COPD as measured by 
biochemical markers of lipid peroxidation [192]. 
 
While the in-vitro investigation of resident fibroblasts with cigarette smoke 
extract resulted in an increased state of senescence, circulating fibrocytes 
seemed unaffected by the cigarette smoke even at much higher 
concentrations. They rather showed enhanced proliferation, which was 
surprising. However, this is in correlation with the later findings of Wang et al, 
where they show increased activation of fibrocytes in patients with chronic 
obstructive asthma through an epidermal growth factor receptor-dependent 
pathway [193]. As this work aimed to focus on cellular senescence, circulating 
fibrocytes were not further pursued. 
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5.4 An in-vitro model of cellular senescence 
 
In order to investigate the relationship between cigarette smoke, DNA damage 
and senescence, an in-vitro model of cellular senescence was established and 
validated. To this end, senescent cells were established by subjecting the cells 
to hydrogen peroxide. Using common molecular markers of senescence like 
its morphology, SA ß-gal assay and SAHF formation[29, 69, 106, 119, 194, 
195] it was further confirmed that the cigarette smoke induced cells in our 
experimental model generated senescent cells. 
 
5.5 β-D Galactosidase activity as a marker of senescence 
 
The most widely used biomarker for senescent and aging cells is senescence-
associated beta-galactosidase (SA-beta-gal), which is defined as beta-
galactosidase activity detectable at pH 6.0 in senescent cells[31]. SA-β-gal 
activity is expressed from GLB1, the gene encoding lysosomal β-D-
galactosidase, the activity of which is typically measured at acidic pH 4.5. 
Lysosomal β-galactosidase displays maximal activity between pH 4.0 and 4.5 
but markedly lower activity at pH 6.0[196]. In fact, β-galactosidase activity is 
not detectable in proliferating cells by in situ staining with X-gal at pH 6.0, the 
conditions used to detect SA-β-gal activity, even though lysosomal β-
galactosidase activity is readily detectible in these cells at acidic pH. 
Nevertheless, based on indirect physiological experiments, it has been 
proposed that increased lysosomal-β-galactosidase activity in senescent cells 
accounts for SA-β-gal activity [33]. Specifically, the levels of total cellular β-
galactosidase activity is higher in late-passage compared to early-passage 
cells at pH 4.5 as well as at pH 6.0, and maximal β-galactosidase activity is 
measurable at low pH in both early- and late-passage cells[33, 197-200]. 
Furthermore, the number and size of lysosomes increase in cells at late 
passage[201, 202]. These results suggest that lysosomal β-galactosidase 
activity increases in senescent cells due to increased lysosome content, 
surpassing a threshold level, so that it is detectable at the suboptimal pH 6.0 
[33, 199].  
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Cells treated with cigarette smoke extract or hydrogen peroxide both contained 
higher lysosomal content as evident from lysosomal β-galactosidase activity 
that  were detected by the formation of a perinuclear blue precipitate. Bright 
field microscopy of stained cells also revealed significant differences. While 
the control cells displayed normal spindly fibroblasts morphology, the 
senescent cells possessed enlarged, flattened shape with prominent vacuoles.  
 
5.6 Senescent Associated Heterochromatin Foci (SAHF) 
 
In addition to a variety of well characterized morphological and biochemical 
changes, senescent cells displays profound changes in its chromatin 
structure. It has been established that senescent cells exhibit excessive 
heterochromatization [203, 204]. The changed chromatin architecture during 
cellular senescence plays a very important role in the senescence program. 
This change in chromatin architecture in senescent cells could be visible at 
the global level when senescent cells are stained with 4′-6-Diamidino-2-
phenylindole (DAPI). Proliferating cells exhibit a diffuse distribution of DNA 
throughout the cell nucleus. However in DAPI-stained senescent cells, 
punctate DNA foci become visible (Figure 14). These foci have been 
described as heterochromatic (so-called senescent associated 
heterochromatin foci (SAHF) [205]. Each SAHF focus in a senescent cell is 
thought to represent an individual chromosome [206, 207]. It has also been 
reported that SAHF do not contain pericentromeres and telomeres, pointing to 
massive heterochromatization of euchromatin in senescent cell [203, 206-
208]. Formation of SAHF has been reported by some to be wholly or partly 
dependent on major effectors of senescence, such as pRB and p53 [203, 
208]. There is large-scale reorganization and heterochromatization during 
formation of SAHF in senescent cells. It has been proposed specifically, that 
the formation of facultative heterochromatin plays an important role in 
mediating several aspects of senescence, including the repression of 
proliferation genes and limiting the DNA damage response [207, 208]. 
Therefore, the heterochromatic modifications induced by cigarette smoke 
extract were investigated in this study. Formation of SAHF was clearly 
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noticeable upon DAPI staining in the CSE treated cells. This suggested that 
the cigarette smoke extract also led to a change in the chromatin landscape 
of the cell. 
 
5.7 Cigarette smoke induce DNA double strand breaks 
 
Subsequently, DNA damage profiles for the respective senescence model 
were investigated. It was found that the senescence induced in our model 
involved DNA double strand breaks. 53 BP1 is a DNA repair protein that is 
known to be recruited at the site of DNA double strand breaks at punctate 
nuclear foci [66, 209]. Our results clearly showed such formation of DNA 
double strand break foci upon cigarette smoke exposure. We also 
investigated for p21 and found that it was expressed more in those cells that 
had more DNA double strand break (DSB) foci [210]. While we noted DNA 
DSB foci in more number of cells, p21 expression was limited to those cells 
which had more punctuate foci of 53 BP1. In other words, not all the cells that 
had 53 BP1 foci, showed increased levels of p21 but all the cells that had 
increased p21 were 53BP1 positive. These results pointed out, that while a 
low level of DNA damage could be self-repaired [211] and the cell does not 
express cell cycle inhibitors, higher expression of p21 for the required cell 
cycle halt occurs only above a threshold level of DNA damage, which was 
induced through the cigarette smoke. Investigating γH2AX levels and the 
presence of heterochromatin protein 1 in the cells upon CSE treatment 
showed, that the γH2AX foci were co-localized with heterochromatin protein 1 
[212], thereby demonstrating the validity of γH2AX as a biomarker. 
 
5.8 Importance of the in-vitro study  
 
An in-vitro model to study the various effects induced by cigarette smoke 
provides an easy, efficient and reproducible method of assessing biological 
changes, which may occur inside the cells. These results could then be 
extrapolated to animal models of cigarette smoke induced disease to 
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investigate any similarities and address number of questions. Detection of 
premature senescence by β-gal or immunofluorescence based (C12FDZ) 
assay could be used for measuring the number of senescent cells. Since 
premature cellular senescence in general could be mediated by several 
factors, it was interesting to understand if persistent DNA damage, that could 
lead to SASP response and hence inflammation, indeed accumulated upon 
chronic exposure to cigarette smoke over a long period of time in mice model 
of emphysema. This could let us understand, if DNA damage indeed may be 
linked to premature cellular senescence of alveolar cells in case of COPD. 
Detection of DNA damage and its quantification could be in addition also 
useful as a prognostic marker of COPD progression.  
 
To sum up the in-vitro data, significantly increased numbers of senescent cells 
upon cigarette smoke extract treatment of human lung fibroblasts were found. 
Cellular senescence could be successfully assessed by staining for β-
galactosidase and evaluation of senescence associated heterochromatin foci 
(SAHF), reflecting condensed chromatin, in the nuclei. DNA double strand 
breaks could be demonstrated and quantified by up regulated γH2AX, 53-
BP1and it’s quantification. Cell cycle arrest could be demonstrated by 
upregulation of p21 at protein level. In-vitro, senescence of lung fibroblasts 
could be induced by 100uM H2O2 as well as by 1% cigarette smoke extract. 
PBMC derived circulating fibrocytes were rather stimulated in growth 
by H2O2 than driven towards senescence. The presence of γH2AX foci in 
fibroblast cells was associated with, apoptosis and pro-inflammatory 
phenotypic changes. The results of this study also showed that the γH2AX foci 
were co-localized with DNA damage thereby demonstrating the validity of 
γH2AX number as a biomarker of DNA damage. 
 
5.9 Studies in the cigarette smoke induced mouse 
emphysema model 
 
As chronic tobacco smoke exposure is regarded as the major cause of the 
disease, chronic cigarette smoke exposure of mice [142][213] has been 
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investigated for a correlation of induction of emphysema and appearance of 
DNA damage over time. Investigation of DNA damage and cell cycle 
inhibition was done in mice exposed for 2, 6 or 8 month to cigarette smoke. 
 
Remarkably, the in-vivo results were in close correlation to the in-vitro results. 
The in-vivo model displayed accumulating DNA damage over time shown by 
γH2AX and 53BP1 levels in the lung sections. Immunofluorescence-based 
assays of γH2AX provide a sensitive, efficient and reproducible method of 
measuring the number of DSBs. Since persistence of γH2AX foci after the 
initial induction of DNA DSBs indicates, that some of the damage remains 
unrepaired, the γH2AX foci is widely used as a biomarker of DNA damage in 
various tissues[214-217]. In the present study, significantly increased 
numbers of γH2AX foci were detected in the alveolar cells. The presence of 
γH2AX foci in these cells was associated with cellular senescence. Western 
blotting is commonly accepted as the gold- standard method for the accurate 
determination of protein levels. We verified the p21 levels with western 
blotting and found that p21 indeed was upregulated upon cigarette smoke 
exposure in the lungs. 
 
5.10  Knocking down of ATM diminished IL6 release upon 
cigarette smoke exposure 
 
The DNA damage response facilitates recognition of DNA damage sites and 
initiates the desired cellular programs to maintain the genomic integrity [218]. 
The cellular programs initiated by DDR ranges from cell cycle checkpoints 
regulation, transcription, translation, DNA repair, metabolism to cell fate 
decisions like cellular senescence or apoptosis. Ataxia telangiectasia mutated 
ATM (Kinase), a master controller of the signal transduction, is central to the 
DNA damage response [219, 220]. Evidence suggests, that the ATM also is 
the key regulator of oxidative stress induced vascular endothelial cell 
senescence [221].  
Though only a subset of SASP factors is driven by DDR signalling [67] it 
becomes very important to understand the role of DDR signalling in SASP 
 98 
 
response as the subset of SASP includes IL-6 and IL-8. The cytokine IL-6 
becomes particularly interesting for the ability of senescent cells to promote 
cancel cell invasion [62].   
Our results suggest that cigarette smoke exposure induces IL-6 release 
representing inflammation during senescence. This release of IL-6 could be 
suppressed by knocking down ATM.  
 
 
 
5.11 Conclusions 
 
The results of the present study suggest that DNA damage, in particular DNA-
doublestrand breaks DSBs caused by cigarette smoke, contributes to the 
molecular pathogenesis of emphysema by inducing cellular senescence, 
apoptosis and pro-inflammatory responses.  
 
The findings may imply, that the DNA damage in the lungs of cigarette smoke 
exposed mice are amplified and/or remain unrepaired, which results in gradual 
accumulation of DNA damage in their lungs. The current theory of the 
pathogenesis of COPD suggests that alveolar destruction is caused by 
interactions between several pathobiological processes, including 
inflammation, apoptosis, cell senescence and oxidative stress. By carefully 
analyzing correlations at both the tissue and cellular levels, we found that DNA 
damage is correlated with apoptosis, cellular senescence and pro-
inflammatory phenotypic changes, thereby underscoring DNA double strand 
breaks as a molecular link between the pathobiological processes thought to 
be involved in the alveolar destruction in COPD. 
 
As a limitation of the study it may be that some of the DNA damage observed 
in may also have been the result of apoptosis, cell senescence and 
inflammation rather than their cause. However, it is well established that DNA 
 99 
 
damage, in particular DSBs, is a strong inducer of apoptosis, cell senescence 
and pro-inflammatory responses in various types of cells and tissues. 
Furthermore, It has been suggested that activation of an ATM/γH2AX-
mediated signaling pathway in response to DSBs, which are of irreparable 
nature, may lead to cellular senescence or apoptosis, thereby eliminating the 
DNA-damaged cells from the tissue and preventing their oncogenic 
transformation [214]. However, the detrimental factor that decides the fate to 
apoptosis or senescence isn’t known. In the present study, we showed that 
DSBs caused by cigarette smoke exposure in mice go along with pro-
inflammatory responses, such as NF kappa B activation, suggesting that 
DSBs may be linked to pro-inflammatory responses. These lines of evidence, 
although not wholly conclusive, support the hypothesis that DNA damage 
plays a causative role in the apoptosis, cell senescence and pro-inflammatory 
responses observed in the lungs of COPD patients. However, future studies 
on animal models of COPD will be needed to show whether this view is 
correct. 
 
Based on the results of the present study, we hypothesize that the cell 
senescence and inflammation, which are thought to represent the 
pathobiological processes of COPD is at least partly linked to DNA damage, 
particularly double strand breaks.  A model is proposed which starts with 
cigarette smoke inducing DNA double strand breaks and activation of DNA 
damage response. The DNA damage response acts to repair the damage or 
drive the cell to arrest depending upon the extent of DNA damage. Chronic or 
persistent DNA damage lead the cell to senescence or apoptosis where as a 
transient DNA damage is repaired by the cell [67]. The DNA damage also 
triggers an inflammatory response. Cellular senescence on the other hand 
also secretes myriads of cytokines further reinforcing inflammation. Hence 
there is an establishment of a vicious loop where senescescent cells reinforce 
inflammation through autocrine and paracrine pathways. Traditional theory of 
the pathogenesis of COPD suggests that activation of inflammation by inhaled 
cigarette smoke and other pollutants plays a central role in airway wall 
thickening, alveolar destruction, airspace enlargement and vascular 
remodeling[222]. Our hypothesis that DNA damage underlies the molecular 
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mechanism of COPD seems to suggest answers to several important 
questions that the traditional theory does not address. The first question is, 
why does COPD take decades to develop? The answer based on our DNA 
damage hypothesis would be that the DNA damage caused by long-term 
smoking needs to accumulate over several decades before COPD develops, 
by analogy to the development of lung cancer. The second question is, why 
does inflammation persist after ceasing to smoke? The answer is that it 
probably persists because smoking-induced DNA damage persists long after 
smoking cessation, as is reported previously [3, 4]. The third question is why 
do corticosteroids have little impact on the inflammation in COPD? The 
answer may be that corticosteroids do not restore the DNA damage. Finally, 
why is it that some smokers develop COPD while others do not and, why are 
COPD smokers more prone to develop lung cancer than non-COPD smokers? 
The answer to the last two questions would be that the greater susceptibility to 
DNA damage due to smoking may be genetically determined just as greater 
susceptibility to smoking-induced lung cancer, so that smokers who are more 
susceptible to DNA damage may be predisposed to both COPD and lung 
cancer. However, the results of the current study do not answer all these 
question; longitudinal studies will be needed that include a larger number of 
COPD patients with different stages of disease severity. 
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Figure 27 A hypothesis suggesting cigarette smoke induced COPD involving DNA 
damage mediated premature cellular senescence.  
Cigarette smoke causes DNA damage (in particular DNA double strand breaks). If the 
damage is persistent, DNA damage induces premature senescence and a pro-
inflammatory response of the lung resident cells. The senescencent cells further 
resleases SASP which reinforces inflammation all of which contribute to the 
development of COPD.  
 
In conclusion, the results of the present study strongly suggest that DNA 
damage at least partly underlies the molecular pathogenesis of COPD. The 
DNA damage hypothesis may help to better understand the pathogenetic 
mechanism of COPD and to target new drugs, such as drugs to prevent DNA 
damage and to modulate responses to the DNA damage that leads to the 
pathobiological processes of COPD and emphysema. 
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6 Summary  
 
Chronic obstructive pulmonary disease (COPD) is an age-associated disease 
caused mainly by cigarette smoking. Deregulated repair, tissue destruction, 
inflammation and lung regression are the hallmarks of COPD. Cellular 
senescence is a signal transduction program leading to irreversible cell cycle 
arrest. The growth arrest can be triggered by several different mechanisms, 
including recognition of DNA double-strand breaks by cellular sensors, leading 
to the activation of cell cycle checkpoint responses and recruitment of DNA 
repair machinery to damaged foci. The execution of regenerative programs in 
lung and remote organs is closely linked to viability or senescence of resident 
cells as well as progenitor cells derived from the circulation. It was proposed 
here, that COPD might be a disease of premature lung senescence and 
therefore this work aimed to decipher markers of DNA damage, repair and 
senescence in lung cell culture and a murine model of cigarette smoke 
induced emphysema.  
 
In-vitro, cellular senescence could be successfully assessed by staining for β-
galactosidase and evaluation of senescence associated heterochromatin foci 
(SAHF), reflecting condensed chromatin, in the nuclei. DNA double strand 
breaks and cell cycle arrest could be demonstrated by up regulated 53-BP1, 
γH2AX and p21. Paraffin lung sections from mice exposed to cigarette smoke 
were investigated for markers of cellular senescence, DNA damage and 
repair. Markers of DNA double strand breaks and senescence were up 
regulated in a time dependent manner, showing a correlation of DNA damage 
and emphysema progression. These results indicated that the pulmonary 
senescence in COPD is linked with persistent DNA double-strand breaks due 
to prolonged cigarette smoking.  
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7 Zusammenfassung  
 
Die chronisch obstruktive Lungenerkrankung (COPD ) ist eine altersbedingte 
Krankheit, die vor allem durch Inhalation von Zigarettenrauch oder anderen 
Rauchgasen verursacht wird. Eingeschränkte Geweberegeneration, verstärkte 
Inflammation und Lungenregression sind zentral an der Pathogenese der 
COPD beteiligt. Zelluläre Seneszenz ist ein Signaltransduktionsprogramm, 
welches zu irreversiblem Zellzyklusarrest führt. Die Wachstumshemmung 
kann durch viele verschiedene Mechanismen ausgelöst werden. Dazu 
gehören die Erkennung von DNA-Doppelstrangbrüchen durch zelluläre 
Sensoren, welche zur Aktivierung von Zellzykluskontrollproteinen führen und 
die Rekrutierung von DNA-Reparaturmaschinerie zu den schadhaften DNA-
Loci initiieren. Die Ausführung des regenerativen Programms der Lunge ist 
eng an Viabilität bzw. Seneszenz der residenten Zellen sowie Vorläuferzellen 
gebunden. Zur Untersuchung der zellulären Seneszenz als Mechanismus der 
Entstehung der COPD adressierte diese Arbeit die Induktion von DNA 
Doppelstrangbrüchen durch Zigarettenrauchextrakt in-vitro, sowie die 
Korrelation von Seneszenz, DNA Doppelstrangbrüchen und 
Emphysemprogression in einem Mausmodell des Zigarettenrauch- induzierten 
Lungenemphysems.  
Zelluläre Seneszenz konnte erfolgreich anhand der β –Galaktosidase Aktivität 
und der Analyse der Seneszenz-assoziierten Heterochromatin-Foci (SAHF) in 
den Zellkernen beurteilt werden. DNA-Doppelstrangbrüche und 
Zellzyklusarrest wurden durch die spezifische Rekrutierung von 53-BP1 und 
γH2AX an die DNA-Reparaturpunkte sowie durch Expression des 
Zellzyklusinhibitors p21 nachgewiesen. Paraffinschnitte von Lungen 
Zigarettenrauch-exponierter Mäuse wurden in Hinsicht auf Seneszenzmarker, 
DNA-Doppelstrangreparatur und Zellzyklusinhibition untersucht. Marker der 
DNA-Doppelstrangbrüche und Seneszenz waren nach längerer 
Rauchexposition in signifikant mehr Zellen exprimiert, als in den gleichaltrigen 
Kontrolltieren. Diese Ergebnisse zeigen, dass DNA Doppelstrangbrüche durch 
Zigarettenrauch-Inhaltsstoffe ausgelöst werden und mit zunehmendem 
experimentellem Emphysem verstärkt auftreten.  
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